| NAG | N-Acetylglucosamine | N-Acetylglucosamine | | C8 H15 N O6 | 221.208 | | 24139 | 0 | 30 | 5 | 30 | 0 | 262 |
| RET | RETINAL | | | C20 H28 O | 284.436 | | 638015 | 0 | 49 | 0 | 49 | 0 | 56 |
| BMA | beta-D-mannopyranose | beta-D-mannose; D-mannose; mannose | | C6 H12 O6 | 180.156 | | 439680 | 0 | 24 | 5 | 24 | 0 | 57 |
| PLM | Palmitic Acid | Palmitinsäure | | C16 H32 O2 | 256.424 | | 985 | 0 | 50 | 0 | 49 | 0 | 67 |
| MAN | alpha-D-mannopyranose | alpha-D-mannose; D-mannose; mannose | | C6 H12 O6 | 180.156 | | 185698 | 0 | 24 | 5 | 24 | 0 | 41 |
| ACM | Acetamide | Acetamide | | C2 H5 N O | 59.067 | | 178 | 0 | 9 | 0 | 8 | 0 | 1 |
| CAU | (S)-carazolol | (S)-Carazolol | | C18 H22 N2 O2 | 298.379 | | 13023332 | 0 | 44 | 1 | 46 | 15 | 13 |
| P32 | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile | | C16 H21 N3 O2 | 287.357 | | 46937143 | 0 | 42 | 1 | 43 | 6 | 8 |
| Y00 | DOBUTAMINE | | | C18 H23 N O3 | 301.38 | | 667531 | 0 | 45 | 1 | 46 | 12 | 5 |
| WHJ | Carmoterol | | | C21 H24 N2 O4 | 368.426 | | 63952 | 0 | 51 | 2 | 53 | 12 | 1 |
| 5FW | ISOPRENALINE | | | C11 H17 N O3 | 211.258 | | 443372 | 0 | 32 | 1 | 32 | 6 | 14 |
| 68H | Levosalbutamol | (-)-Albuterol | | C13 H21 N O3 | 239.311 | | 123600 | 0 | 38 | 1 | 38 | 6 | 4 |
| I32 | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3-iodo-1H-indole-2-carbonitrile | IODOCYANOPINDOLOL | | C16 H20 I N3 O2 | 413.253 | | 52918356 | 0 | 42 | 1 | 43 | 10 | 1 |
| ADN | Adenosine | Ado | | C10 H13 N5 O4 | 267.241 | | 60961 | 0 | 32 | 4 | 34 | 10 | 19 |
| NEC | N-Ethyl-5'-Carboxamido Adenosine | N-Ethyl-5'-Carboxamido Adenosine | | C12 H16 N6 O4 | 308.293 | | 448222 | 0 | 38 | 4 | 40 | 10 | 9 |
| TIM | Timolol | Timolol anhydrous | | C13 H24 N4 O3 S | 316.42 | | 33624 | 0 | 45 | 1 | 46 | 5 | 3 |
| ZMA | 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | | C16 H15 N7 O2 | 337.336 | | 176407 | 0 | 40 | 0 | 43 | 22 | 31 |
| JRZ | (2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]butan-2-ol | | | C17 H27 N O2 | 277.402 | | 5311179 | 0 | 47 | 2 | 48 | 6 | 2 |
| JSZ | ethyl 4-({(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)-3-methyl-1-benzofuran-2-carboxylate | | | C18 H25 N O5 | 335.395 | | 913103 | 0 | 49 | 1 | 50 | 10 | 1 |
| JTZ | (2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol | | | C15 H23 N O2 | 249.349 | | 204665 | 0 | 41 | 1 | 41 | 6 | 5 |
| ITD | (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate | | | C21 H34 N4 S2 | 406.651 | | 25147749 | 0 | 61 | 0 | 64 | 0 | 7 |
| ALN | 1-Naphthyl-L-alanine | - (S)-2-Amino-3-(naphthalen-1-yl)propanoic acid
- L-beta-(1-Naphthyl)alanine
- 1-Naphthyl-L-alanine
- Naphthalen-2-yl-3-alanine
| | C13 H13 N O2 | 215.248 | | 6950503 | 0 | 29 | 1 | 30 | 11 | 1 |
| DPR | D-Proline | D-Proline | | C5 H9 N O2 | 115.13 | | 6971012 | 0 | 17 | 1 | 17 | 0 | 1 |
| CIR | Citrulline | Citrulline | | C6 H13 N3 O3 | 175.186 | | 9750 | 0 | 25 | 1 | 24 | 0 | 1 |
| P0G | 8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one | | | C21 H26 N2 O4 | 370.442 | | 49837874 | 0 | 53 | 1 | 55 | 12 | 10 |
| ETQ | Eticlopride | - Eticloprida
- Eticlopridum
- Eticlopride hydrochloride
- Eticlopride
| | C17 H25 Cl N2 O3 | 340.845 | | 57267 | 0 | 48 | 1 | 49 | 6 | 1 |
| ERC | 8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-one | | | C23 H28 N2 O5 S | 444.544 | | 49835963 | 0 | 59 | 1 | 61 | 12 | 1 |
| UKA | UK-432097 | UK-432097 | | C40 H47 N11 O6 | 777.871 | | 9833519 | 0 | 104 | 4 | 110 | 28 | 4 |
| XAC | N-(2-aminoethyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide | | | C21 H28 N6 O4 | 428.485 | | 5697 | 0 | 59 | 0 | 61 | 12 | 1 |
| CFF | Caffeine | Caffeine citrate | | C8 H10 N4 O2 | 194.191 | | 2519 | 0 | 24 | 0 | 25 | 10 | 2 |
| D7V | Cidoxepin | - (Z)-Doxepin
- Cidoxepin hydrochloride
- Cidoxepinum
- Cidoxepina
- Cidoxepin
| | C19 H21 N O | 279.376 | | 667468 | 0 | 42 | 0 | 44 | 12 | 1 |
| QNB | (3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate | | | C21 H23 N O3 | 337.412 | | 688566 | 0 | 48 | 1 | 51 | 12 | 2 |
| T4G | 6-(2,6-dimethylpyridin-4-yl)-5-phenyl-1,2,4-triazin-3-amine | | | C16 H15 N5 | 277.324 | | 56844240 | 0 | 36 | 0 | 38 | 18 | 1 |
| T4E | 4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol | | | C15 H11 Cl N4 O | 298.727 | | 135566609 | 0 | 32 | 0 | 34 | 18 | 4 |
| ML5 | {(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acid | | | C16 H27 N2 O4 P | 342.37 | | 6857802 | 0 | 50 | 1 | 50 | 6 | 2 |
| VPX | Vorapaxar | [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-Fluorophényl)-2-pyridinyl]vinyl}-1-méthyl-3-oxododécahydronaphto[2,3-c]furan-6-yl]carbamate d'éthyle | | C29 H33 F N2 O4 | 492.582 | | 10077130 | 0 | 69 | 7 | 73 | 12 | 1 |
| NA | SODIUM ION | | | Na | 22.99 | | | 1 | 1 | 0 | 0 | 0 | 79 |
| XF5 | 4-(PIPERAZIN-1-YL)-1H-INDOLE | | | C12 H15 N3 | 201.268 | | 594590 | 0 | 30 | 0 | 32 | 10 | 1 |
| 3WC | 4-METHYL-2-(PIPERAZIN-1-YL) QUINOLINE | | | C14 H17 N3 | 227.305 | | 598754 | 0 | 34 | 0 | 36 | 11 | 1 |
| G90 | 2-[(2S)-3-[[1-(1H-indol-3-yl)-2-methyl-propan-2-yl]amino]-2-oxidanyl-propoxy]benzenecarbonitrile | BUCINDOLOL | | C22 H25 N3 O2 | 363.453 | | 12619631 | 0 | 52 | 1 | 54 | 16 | 1 |
| CVD | (2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOXY)ETHYLAMINO]PROPAN-2-OL | CARVEDILOL | | C24 H26 N2 O4 | 406.474 | | 185395 | 0 | 56 | 1 | 59 | 21 | 2 |
| 0HK | Tiotropium | Tiotropium | | C19 H22 N O4 S2 | 392.512 | | | 1 | 48 | 4 | 52 | 10 | 6 |
| JDC | (3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl}-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | | | C28 H39 N3 O3 | 465.628 | | 9956146 | 0 | 73 | 4 | 76 | 12 | 7 |
| BF0 | methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate | beta-funaltrexamine, bound form | | C25 H32 N2 O6 | 456.531 | | 137348997 | 0 | 65 | 5 | 70 | 6 | 1 |
| 0NN | 1-benzyl-N-[3-(1'H,3H-spiro[2-benzofuran-1,4'-piperidin]-1'-yl)propyl]-D-prolinamide | | | C27 H35 N3 O2 | 433.586 | | 10296561 | 0 | 67 | 1 | 71 | 12 | 1 |
| EJ4 | (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol | Naltrindole | | C26 H26 N2 O3 | 414.496 | | 5497186 | 0 | 57 | 4 | 64 | 16 | 2 |
| 2GM | Dihydroergotamine | Dihydroergotamine | | C33 H37 N5 O5 | 583.677 | | 10531 | 0 | 80 | 7 | 87 | 16 | 1 |
| ERM | Ergotamine | Ergotamina | | C33 H35 N5 O5 | 581.661 | | 8223 | 0 | 78 | 6 | 85 | 16 | 6 |
| BOG | octyl beta-D-glucopyranoside | Beta-Octylglucoside; octyl beta-D-glucoside; octyl D-glucoside; octyl glucoside | | C14 H28 O6 | 292.369 | | 62852 | 0 | 48 | 5 | 48 | 0 | 7 |
| 1KS | Taladegib | Taladegib | | C26 H24 F4 N6 O | 512.502 | | 49848070 | 0 | 61 | 0 | 65 | 22 | 2 |
| 1Q5 | 3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine | | | C21 H30 N2 O | 326.476 | | 9862166 | 0 | 54 | 0 | 55 | 12 | 2 |
| XQC | 4-[(1R)-1-hydroxy-2-{[1-(4-hydroxyphenyl)-2-methylpropan-2-yl]amino}ethyl]benzene-1,2-diol | | | C18 H23 N O4 | 317.38 | | 44328881 | 0 | 46 | 1 | 47 | 12 | 1 |
| ALE | Epinephrine | Adrenaline | | C9 H13 N O3 | 183.204 | | 139148732 | 0 | 26 | 1 | 26 | 6 | 8 |
| MRV | Maraviroc | | | C29 H41 F2 N5 O | 513.666 | | | 0 | 78 | 3 | 82 | 11 | 1 |
| IXO | 4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium | Iperoxo | | C10 H17 N2 O2 | 197.254 | | 10104167 | 1 | 31 | 0 | 31 | 0 | 17 |
| 2CU | 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide | LY2119620 positive allosteric modulator of M2/M4 receptor | | C19 H24 Cl N5 O3 S | 437.944 | | 57664406 | 0 | 53 | 0 | 56 | 10 | 10 |
| SNT | (E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methanimine | SANT-1 | | C23 H27 N5 | 373.494 | | 6878030 | 0 | 55 | 0 | 58 | 17 | 1 |
| AZJ | ethyl 6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methylpyridine-3-carboxylate | | | C23 H26 N4 O5 S | 470.541 | | 23649325 | 0 | 59 | 0 | 61 | 12 | 1 |
| CY8 | Cyclopamine | (3alpha,8alpha,14beta,22S,23R)-17,23-epoxyveratraman-3-ol | | C27 H41 N O2 | 411.62 | | 442972 | 0 | 71 | 10 | 76 | 0 | 2 |
| YCM | Cysteine-S-acetamide | CYSTEINE-S-ACETAMIDE | | C5 H10 N2 O3 S | 178.209 | | 36688842 | 0 | 21 | 1 | 20 | 0 | 22 |
| 2U8 | Mavoglurant | methyl (3aR,4S,7aR)-4-hydroxy-4-[(3-methylphenyl)ethynyl]octahydro-1H-indole-1-carboxylate | | C19 H23 N O3 | 313.391 | | 9926832 | 0 | 46 | 3 | 48 | 6 | 1 |
| FM9 | 4-fluoro-N-methyl-N-{4-[6-(propan-2-ylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl}benzamide | | | C18 H18 F N5 O S | 371.432 | | 16660135 | 0 | 44 | 0 | 46 | 17 | 1 |
| 2YB | Fasiglifam | Fasiglifam | | C29 H32 O7 S | 524.625 | | 24857286 | 0 | 69 | 1 | 72 | 18 | 5 |
| 6AD | 2-(methylsulfanyl)adenosine 5'-(trihydrogen diphosphate) | 2-methylthio-adenosine-5'-diphosphate | | C11 H17 N5 O10 P2 S | 473.293 | | 121990 | 0 | 46 | 4 | 48 | 10 | 5 |
| 6AT | 2-(methylsulfanyl)adenosine 5'-(tetrahydrogen triphosphate) | 2-methylthio-adenosine-5'-triphosphate | | C11 H18 N5 O13 P3 S | 553.273 | | 5310983 | 0 | 51 | 4 | 53 | 10 | 1 |
| A8T | 2-{6-[4-(4-benzylphthalazin-1-yl)piperazin-1-yl]pyridin-3-yl}propan-2-ol | | | C27 H29 N5 O | 439.552 | | 24905375 | 0 | 62 | 0 | 66 | 23 | 1 |
| SG8 | 3-chloro-4,7-difluoro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide | | | C28 H26 Cl F2 N3 O S | 526.04 | | | 0 | 62 | 0 | 66 | 22 | 1 |
| 35V | 4-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(2-sulfanylethoxy)phenyl]ethyl}amino)ethyl]benzene-1,2-diol | | | C19 H25 N O5 S | 379.471 | | 76210628 | 0 | 51 | 1 | 52 | 12 | 1 |
| DI7 | 2,6-dimethyl-L-tyrosine | | | C11 H15 N O3 | 209.242 | | 40580600 | 0 | 30 | 1 | 30 | 6 | 3 |
| DI8 | (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | | | C10 H11 N O2 | 177.2 | | 2733226 | 0 | 24 | 1 | 25 | 6 | 2 |
| SUV | Suvorexant | suvorexant | | C23 H23 Cl N6 O2 | 450.921 | | 24965990 | 0 | 55 | 1 | 59 | 21 | 4 |
| 3C0 | Methscopolamine | (1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane | | C18 H24 N O4 | 318.387 | | | 1 | 47 | 5 | 50 | 6 | 4 |
| NGI | 2-[P-(2-CARBOXYETHYL)PHENYLETHYL-AMINO]-5'-N-ETHYLCARBOXAMIDO ADENOSINE | | | C23 H29 N7 O6 | 499.52 | | 3086599 | 0 | 65 | 4 | 68 | 16 | 3 |
| BNG | B-nonylglucoside | Beta-NONYLGLUCOSIDE; nonyl beta-D-glucoside; nonyl D-glucoside; nonyl glucoside | | C15 H30 O6 | 306.395 | | 155448 | 0 | 51 | 5 | 51 | 0 | 2 |
| BUR | 1-[2-(2-tert-butylphenoxy)pyridin-3-yl]-3-[4-(trifluoromethoxy)phenyl]urea | | | C23 H22 F3 N3 O3 | 445.434 | | 11510579 | 0 | 54 | 0 | 56 | 18 | 1 |
| 2ID | [(1R,2S,4S,5S)-4-[2-iodo-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hex-1-yl]methyl dihydrogen phosphate | | | C13 H18 I N5 O8 P2 | 561.163 | | 44448831 | 0 | 47 | 4 | 50 | 10 | 1 |
| PCA | Pidolic acid | L-pyroglutamic acid | | C5 H7 N O3 | 129.114 | | 7405 | 0 | 16 | 1 | 16 | 0 | 29 |
| ZD7 | 5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-3,4-dihydro-1,6-naphthyridin-2(1H)-one | | | C26 H26 N6 O | 438.524 | | 4673492 | 0 | 59 | 0 | 63 | 23 | 1 |
| ON7 | {1-[(2S,3S)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1H-pyrrol-3-yl}acetic acid | ONO9780307 | | C30 H35 N O7 | 521.601 | | 11785732 | 0 | 73 | 2 | 76 | 17 | 1 |
| ON9 | 3-{1-[(2S,3S)-3-(4-acetyl-3,5-dimethoxyphenyl)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1H-pyrrol-3-yl}propanoic acid | ONO-9910539 | | C32 H37 N O8 | 563.638 | | 91799237 | 0 | 78 | 2 | 81 | 17 | 1 |
| ON3 | 1-(4-{[(2S,3R)-2-(2,3-dihydro-1H-inden-2-yloxy)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]oxy}phenyl)cyclopropanecarboxylic acid | ONO-3080573 | | C31 H34 O7 | 518.597 | | 91799238 | 0 | 72 | 2 | 76 | 18 | 1 |
| 4OT | [5-(2-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]{(2S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]pyrrolidin-1-yl}methanone | | | C24 H21 F N4 O2 S | 448.513 | | 10204153 | 0 | 53 | 1 | 57 | 22 | 1 |
| OLM | Olmesartan | - Olmesartan medoxomil
- 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
- Olmesartan
- 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
| | C24 H26 N6 O3 | 446.502 | | 158781 | 0 | 59 | 0 | 62 | 22 | 2 |
| XTK | 4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-7-methyl-1H-indole-2-carbonitrile | | | C17 H23 N3 O2 | 301.383 | | 91885640 | 0 | 45 | 1 | 46 | 10 | 1 |
| VF1 | (2R,3S,3aR,5aR,6R,11bR,11cS)-3a-methoxy-3,14-dimethyl-2-phenyl-2,3,3a,6,7,11c-hexahydro-1H-6,11b-(epiminoethano)-3,5a-methanonaphtho[2,1-g]indol-10-ol | BU72 | | C28 H32 N2 O2 | 428.566 | | | 0 | 64 | 7 | 70 | 12 | 2 |
| 51D | 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile | | | C14 H7 Cl F N5 | 299.69 | | 86280685 | 0 | 28 | 0 | 30 | 17 | 1 |
| 51E | 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile | | | C16 H8 Cl F N4 | 310.713 | | 86763358 | 0 | 30 | 0 | 32 | 18 | 1 |
| DGV | 1-benzyl-N-{3-[4-(2,6-dichlorophenyl)piperidin-1-yl]propyl}-D-prolinamide | | | C26 H33 Cl2 N3 O | 474.466 | | 25001412 | 0 | 65 | 1 | 68 | 12 | 1 |
| DGW | (5S,7S)-7-{[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl}-1-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ol | | | C24 H29 Cl2 N O | 418.399 | | 10047612 | 0 | 57 | 2 | 60 | 12 | 1 |
| 5MV | MK-0893 | MK-0893 | | C32 H27 Cl2 N3 O4 | 588.48 | | 11570626 | 0 | 68 | 1 | 72 | 28 | 1 |
| 6DY | 2-(furan-2-yl)-N~5~-[2-(4-phenylpiperidin-1-yl)ethyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine | | | C21 H24 N8 O | 404.468 | | 86302363 | 0 | 54 | 0 | 58 | 21 | 1 |
| 6DZ | 2-(furan-2-yl)-N~5~-[2-(4-methylpiperazin-1-yl)ethyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine | | | C15 H21 N9 O | 343.387 | | 121225598 | 0 | 46 | 0 | 49 | 15 | 1 |
| 6DX | 2-(furan-2-yl)-N~5~-[3-(4-phenylpiperazin-1-yl)propyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine | | | C21 H25 N9 O | 419.483 | | 44394688 | 0 | 56 | 0 | 60 | 21 | 1 |
| 6DV | N~5~-{2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl}-2-(furan-2-yl)[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine | | | C20 H21 F2 N9 O | 441.437 | | 44394716 | 0 | 53 | 0 | 57 | 21 | 1 |
| 6XQ | (3~{S})-3-cyclopropyl-3-[2-[1-[2-[2,2-dimethylpropyl-(6-methylpyridin-2-yl)carbamoyl]-5-methoxy-phenyl]piperidin-4-yl]-1-benzofuran-6-yl]propanoic acid | | | C38 H45 N3 O5 | 623.781 | | 133053953 | 0 | 91 | 1 | 96 | 22 | 1 |
| CLR | Cholesterol | - Cholesterol
- Cholesterin
- Cholest-5-en-3beta-ol
- (3β,14β,17α)-cholest-5-en-3-ol
| | C27 H46 O | 386.654 | | 5997 | 0 | 74 | 8 | 77 | 0 | 22 |
| VIS | Vismodegib | - Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-
- 2-chloro-N-(4-chloro-3-pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide
- Vismodegibum
- Vismodegib
- Vismodégib
| | C19 H14 Cl2 N2 O3 S | 421.297 | | 24776445 | 0 | 41 | 0 | 43 | 18 | 1 |
| 79K | Vercirnon | Vercirnon | | C22 H21 Cl N2 O4 S | 444.931 | | 10343454 | 0 | 51 | 0 | 53 | 18 | 1 |
| TEP | Theophylline | Theophylline | | C7 H8 N4 O2 | 180.164 | | 2153 | 0 | 21 | 0 | 22 | 10 | 3 |
| 8JN | 1-butyl-3-[(~{E})-3-oxidanylprop-1-enyl]-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione | | | C21 H28 N4 O3 | 384.472 | | | 0 | 56 | 2 | 60 | 5 | 1 |
| 8K8 | 1-butyl-3-(3-oxidanylpropyl)-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione | | | C21 H30 N4 O3 | 386.488 | | | 0 | 58 | 2 | 62 | 5 | 1 |
| 8TZ | (~{S})-(4-fluoranyl-2-propyl-phenyl)-(1~{H}-imidazol-2-yl)methanol | | | C13 H15 F N2 O | 234.269 | | 126961334 | 0 | 32 | 1 | 33 | 11 | 1 |
| 8UN | 2-(6-bromanyl-1,3-benzodioxol-5-yl)-~{N}-(4-cyanophenyl)-1-[(1~{S})-1-cyclohexylethyl]benzimidazole-5-carboxamide | | | C30 H27 Br N4 O3 | 571.464 | | 126961335 | 0 | 65 | 1 | 70 | 22 | 1 |
| 9DK | 3-[2-(1~{H}-imidazol-4-yl)ethylamino]-2,2-dimethyl-3-oxidanylidene-propanoic acid | | | C10 H15 N3 O3 | 225.244 | | 82821116 | 0 | 31 | 0 | 31 | 5 | 1 |
| 9DQ | (2~{S})-2-azanyl-3-(1~{H}-1,2,3,4-tetrazol-5-yl)propanoic acid | | | C4 H7 N5 O2 | 157.131 | | 3246533 | 0 | 18 | 1 | 18 | 5 | 1 |
| 9DT | (2~{S})-2-azanyl-3-(2-fluorophenyl)-2-methyl-propanoic acid | | | C10 H12 F N O2 | 197.206 | | 14605998 | 0 | 26 | 1 | 26 | 6 | 1 |
| 9DW | (2~{S})-2-azanyl-3-[4-(2-ethyl-4-methoxy-phenyl)phenyl]propanoic acid | | | C18 H21 N O3 | 299.364 | | 67243038 | 0 | 43 | 1 | 44 | 12 | 1 |
| 9DZ | (2~{S})-2-azanyl-5-(3,5-dimethylphenyl)pentanamide | | | C13 H20 N2 O | 220.311 | | 137348806 | 0 | 36 | 1 | 36 | 6 | 1 |
| 9P2 | 1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine | | | C36 H35 N3 O4 | 573.681 | | 10210160 | 0 | 78 | 0 | 84 | 29 | 3 |
| 9XT | Vipadenant | Vipadenant | | C16 H15 N7 O | 321.337 | | 21874557 | 0 | 39 | 0 | 42 | 21 | 1 |
| 9XW | Tozadenant | Tozadenant | | C19 H26 N4 O4 S | 406.499 | | 11618368 | 0 | 54 | 0 | 57 | 10 | 1 |
| 9Y2 | 4-(3,3-dimethylbutanoylamino)-3,5-bis(fluoranyl)-~{N}-(1,3-thiazol-2-yl)benzamide | | | C16 H17 F2 N3 O2 S | 353.387 | | 16122818 | 0 | 41 | 0 | 42 | 11 | 2 |
| 73R | (3S)-1-{(1S,2R,4R)-4-[methyl(propan-2-yl)amino]-2-propylcyclohexyl}-3-{[6-(trifluoromethyl)quinazolin-4-yl]amino}pyrrolidin-2-one | | | C26 H36 F3 N5 O | 491.592 | | 68764898 | 0 | 71 | 4 | 74 | 11 | 1 |
| VT5 | (2~{R})-1-(4-chloranyl-2-fluoranyl-phenyl)-2-cyclohexyl-3-ethanoyl-4-oxidanyl-2~{H}-pyrrol-5-one | | | C18 H19 Cl F N O3 | 351.8 | | 12093170 | 0 | 43 | 1 | 45 | 6 | 1 |
| 7AB | (2E)-{(4E)-4-[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene]cyclohex-2-en-1-ylidene}acetaldehyde | | | C21 H28 O | 296.446 | | 6438558 | 0 | 50 | 0 | 51 | 0 | 1 |
| ZDG | 4-[4-[2-(2,4-dichlorophenyl)-4-methyl-5-(piperidin-1-ylcarbamoyl)pyrazol-3-yl]phenyl]but-3-ynyl nitrate | | | C26 H25 Cl2 N5 O4 | 542.414 | | 46912833 | 0 | 62 | 0 | 65 | 17 | 1 |
| 7LD | Lysergic acid diethylamide | N,N-diethyl-(+)-lysergamide | | C20 H25 N3 O | 323.432 | | 5761 | 0 | 49 | 2 | 52 | 10 | 16 |
| MK6 | MK-8666 | MK-8666 | | C29 H31 N O6 S | 521.625 | | 73051869 | 0 | 68 | 3 | 72 | 18 | 2 |
| 7DY | Taranabant | Taranabant | | C27 H25 Cl F3 N3 O2 | 515.955 | | 11226090 | 0 | 61 | 2 | 63 | 18 | 2 |
| DU1 | 4-{[3-(8-cyclohexyl-2,6-dioxo-1-propyl-1,2,6,7-tetrahydro-3H-purin-3-yl)propyl]carbamoyl}benzene-1-sulfonyl fluoride | | | C24 H30 F N5 O5 S | 519.589 | | 10839674 | 0 | 66 | 0 | 69 | 11 | 1 |
| 8D1 | 5-amino-N-[(2-methoxyphenyl)methyl]-2-(3-methylphenyl)-2H-1,2,3-triazole-4-carboximidamide | | | C18 H20 N6 O | 336.391 | | 124081196 | 0 | 45 | 0 | 47 | 17 | 1 |
| 8ES | N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)thiophene-2-carboxamide | | | C36 H29 N7 O2 S | 623.726 | | 15780052 | 0 | 75 | 0 | 81 | 34 | 2 |
| 8EM | N-[(furan-2-yl)methyl]-N-(4-oxo-2-propyl-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-3,4-dihydroquinazolin-6-yl)benzamide | | | C37 H31 N7 O3 | 621.687 | | 126456406 | 0 | 78 | 0 | 84 | 34 | 1 |
| 89F | 1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine | Methiothepin; Metitepine | | C20 H24 N2 S2 | 356.548 | | 7059581 | 0 | 48 | 1 | 51 | 12 | 3 |
| 836 | N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide | | | C26 H24 F3 N7 O3 | 539.509 | | 126970683 | 0 | 63 | 0 | 67 | 22 | 2 |
| HRG | L-homoarginine | Homo-L-arginine | | C7 H16 N4 O2 | 188.228 | | 9085 | 0 | 29 | 1 | 28 | 0 | 4 |
| ALC | 3-Cyclohexyl-L-alanine | - beta-Cyclohexyl-alanine
- β-Cyclohexyl-alanine
- 3-Cyclohexyl-L-alanine
- beta-Cyclohexyl-L-alanine
| | C9 H17 N O2 | 171.237 | | 712421 | 0 | 29 | 1 | 29 | 0 | 5 |
| OIC | L-Octahydroindole-2-carboxylic acid | - Perindopril impurity A
- (2S,3aS,7aS)-2-Carboxyoctahydroindole
- L-Octahydroindole-2-carboxylic acid
- (2S,3aS,7aS)-Octahydroindole-2-carboxylic acid
| | C9 H15 N O2 | 169.221 | | 7408452 | 0 | 27 | 3 | 28 | 0 | 1 |
| NLE | Norleucine | | | C6 H13 N O2 | 131.173 | | 21236 | 0 | 22 | 1 | 21 | 0 | 26 |
| 200 | 4-CHLORO-L-PHENYLALANINE | | | C9 H10 Cl N O2 | 199.634 | | 736190 | 0 | 23 | 1 | 23 | 6 | 1 |
| CSD | 3-sulfino-L-alanine | 3-Sulphino-L-alanine | | C3 H7 N O4 S | 153.157 | | 28167170 | 0 | 16 | 1 | 15 | 0 | 2 |
| 97Y | N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine | | | C26 H28 F3 N5 O3 | 515.527 | | 68178630 | 0 | 65 | 1 | 68 | 17 | 5 |
| 97V | 4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide | | | C29 H31 N7 O4 S | 573.666 | | 23549991 | 0 | 72 | 0 | 76 | 23 | 3 |
| TPO | PHOSPHOTHREONINE | PHOSPHONOTHREONINE | | C4 H10 N O6 P | 199.099 | | 139055008 | 0 | 22 | 2 | 21 | 0 | 12 |
| SEP | Dexfosfoserine | PHOSPHONOSERINE | | C3 H8 N O6 P | 185.072 | | 68841 | 0 | 19 | 1 | 18 | 0 | 16 |
| AQD | Nemonapride | N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide | | C21 H26 Cl N3 O2 | 387.903 | | 156333 | 0 | 53 | 2 | 55 | 12 | 2 |
| 7MA | N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl)sulfonyl-amino]-N-(pyridin-3-ylmethyl)ethanamide | | | C23 H26 N4 O4 S | 454.542 | | 9981404 | 0 | 58 | 0 | 60 | 18 | 4 |
| 7Y9 | 4-[[3-[[4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy]methyl]phenyl]methoxy]benzenecarboximidamide | | | C30 H30 N2 O3 | 466.571 | | 9956189 | 0 | 65 | 0 | 68 | 24 | 1 |
| 8VS | 4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide | | | C34 H39 Br N4 O4 | 647.602 | | 129318963 | 0 | 82 | 3 | 85 | 18 | 1 |
| K87 | 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxy-N-(2,6-dimethylphenyl)propanamide | | | C36 H38 N6 O6 S | 682.789 | | 9810112 | 0 | 87 | 0 | 91 | 30 | 1 |
| SAR | Sarcosine | Sarcosine | | C3 H7 N O2 | 89.093 | | 7311726 | 0 | 13 | 0 | 12 | 0 | 8 |
| K86 | Bosentan | bosentan anhydrous | | C27 H29 N5 O6 S | 551.614 | | 104865 | 0 | 68 | 0 | 71 | 24 | 1 |
| 8D0 | (6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol | | | C26 H39 N O3 S | 445.658 | | 102336704 | 0 | 70 | 3 | 72 | 6 | 7 |
| 8D3 | (6aR,10aR)-3-(8-bromanyl-2-methyl-octan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | | | C25 H37 Br O2 | 449.464 | | 53318931 | 0 | 65 | 2 | 67 | 6 | 1 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 1-Oleoyl-R-glycerol | | C21 H40 O4 | 356.54 | | 11451146 | 0 | 65 | 1 | 64 | 0 | 1 |
| 8VL | 4-[2-[[(2R)-2-(4-bromanylnaphthalen-1-yl)propanoyl]amino]-4-cyano-phenyl]butanoic acid | | | C24 H21 Br N2 O3 | 465.339 | | 135121352 | 0 | 51 | 1 | 53 | 17 | 1 |
| 7UR | 4-[4-cyano-2-[[(2R)-2-(4-fluoranylnaphthalen-1-yl)propanoyl]amino]phenyl]butanoic acid | | | C24 H21 F N2 O3 | 404.434 | | 92978378 | 0 | 51 | 1 | 53 | 17 | 1 |
| 9AF | dimethyl 4-{3-[({3-[4-(3-methoxyphenyl)piperidin-1-yl]propyl}carbamoyl)amino]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | | | C33 H42 N4 O6 | 590.71 | | 9960164 | 0 | 85 | 0 | 88 | 12 | 1 |
| 9AO | N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-N~5~-(N'-{[2-(propanoylamino)ethyl]carbamoyl}carbamimidoyl)-D-ornithinamide | | | C33 H41 N7 O5 | 615.723 | | 127041619 | 0 | 86 | 1 | 88 | 18 | 1 |
| 9EC | (1R,2R,4S,5S,7s)-7-({[4-fluoro-2-(thiophen-2-yl)phenyl]carbamoyl}oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium | | | C20 H22 F N2 O3 S | 389.464 | | | 1 | 49 | 5 | 53 | 11 | 1 |
| 82F | N-[2-[(2S)-2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxidanylidene-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide | | | C27 H38 N6 O2 | 478.63 | | 6604853 | 0 | 73 | 1 | 76 | 12 | 1 |
| 9ER | N1,N1-dimethyl-N2-[(pyridin-3-yl)methyl]-N2-{4-[2,4,6-tri(propan-2-yl)phenyl]-1,3-thiazol-2-yl}ethane-1,2-diamine | | | C28 H40 N4 S | 464.709 | | 119368 | 0 | 73 | 0 | 75 | 17 | 1 |
| 9EU | 4-ethynyl-3-{3-fluoro-4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl]benzene-1-carbonyl}-N,N-dimethyl-1H-indole-1-carboxamide | | | C28 H22 F N5 O2 | 479.505 | | 154087 | 0 | 58 | 0 | 62 | 26 | 1 |
| 9JU | N-(adamantan-1-yl)-1-(5-hydroxypentyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxamide | | | C26 H35 N3 O2 | 421.575 | | | 0 | 66 | 0 | 70 | 11 | 1 |
| 8NU | Risperidone | - Risperidona
- Rispéridone
- Risperidone tartrate
- Risperidone
- Risperidonum
| | C23 H27 F N4 O2 | 410.484 | | 5073 | 0 | 57 | 0 | 61 | 10 | 2 |
| ZOT | Zotepine | | | C18 H18 Cl N O S | 331.86 | | 5736 | 0 | 40 | 0 | 42 | 12 | 1 |
| P2E | Dinoprostone | Dinoprostona | | C20 H32 O5 | 352.465 | | 5280360 | 0 | 57 | 4 | 57 | 0 | 14 |
| A4R | N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-2-yl)propyl]cyclopentanecarboxamide | | | C26 H39 N5 O S | 469.686 | | | 0 | 72 | 4 | 76 | 10 | 1 |
| A4X | 4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-3-yl)propyl]cyclohexane-1-carboxamide | | | C27 H39 F2 N5 O S | 519.693 | | | 0 | 75 | 4 | 79 | 10 | 1 |
| CVV | N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide | | | C27 H27 I N2 O3 | 554.419 | | 131955138 | 0 | 60 | 5 | 66 | 12 | 1 |
| E2J | Ritanserin | Ritanserin | | C27 H25 F2 N3 O S | 477.569 | | 5074 | 0 | 59 | 0 | 63 | 12 | 1 |
| ORN | Ornithine | Ornithine oxoglurate | | C5 H12 N2 O2 | 132.161 | | 6262 | 0 | 21 | 1 | 20 | 0 | 2 |
| ZAL | 3-cyclohexyl-D-alanine | | | C9 H17 N O2 | 171.237 | | 25322977 | 0 | 29 | 1 | 29 | 0 | 8 |
| EFD | Avacopan | (2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzene-1-carbonyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide | | C33 H35 F4 N3 O2 | 581.644 | | 49841217 | 0 | 77 | 2 | 81 | 18 | 1 |
| FSY | Fevipiprant | (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid | | C19 H17 F3 N2 O4 S | 426.409 | | 23582412 | 0 | 46 | 0 | 48 | 16 | 1 |
| FT4 | [(3R)-3-{[(4-fluorophenyl)sulfonyl](methyl)amino}-1,2,3,4-tetrahydro-9H-carbazol-9-yl]acetic acid | CAY10471 | | C21 H21 F N2 O4 S | 416.466 | | 25817650 | 0 | 50 | 1 | 53 | 16 | 1 |
| DAL | D-Alanine | (R)-alanine | | C3 H7 N O2 | 89.093 | | 71080 | 0 | 13 | 1 | 12 | 0 | 31 |
| MEA | N-METHYLPHENYLALANINE | | | C10 H13 N O2 | 179.216 | | 6951134 | 0 | 26 | 1 | 26 | 6 | 21 |
| ETA | Ethanolamine | - Ethanolamine hydrochloride
- Ethanolamine acetate
- Ethanolamine
| | C2 H7 N O | 61.083 | | 700 | 0 | 11 | 0 | 10 | 0 | 14 |
| H8G | Lisuride | N'-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylurea | | C20 H26 N4 O | 338.447 | | 28864 | 0 | 51 | 2 | 54 | 10 | 6 |
| H8D | Methylergometrine | Methylergobasin | | C20 H25 N3 O2 | 339.431 | | 8226 | 0 | 50 | 3 | 53 | 10 | 3 |
| H8J | (8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | methysergide | | C21 H27 N3 O2 | 353.458 | | 9681 | 0 | 53 | 3 | 56 | 10 | 1 |
| H8M | (1S)-1-[(2-chloro-3,4-dimethoxyphenyl)methyl]-6-methyl-2,3,4,9-tetrahydro-1H-beta-carboline | LY266097 | | C21 H23 Cl N2 O2 | 370.873 | | 92460087 | 0 | 49 | 1 | 52 | 16 | 1 |
| L76 | 1-(4-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1H-1,2,3-triazol-5-yl)-N,N-dimethylmethanamine | | | C26 H28 F7 N5 O2 | 575.522 | | 9809077 | 0 | 68 | 3 | 71 | 17 | 1 |
| D7W | Fenobam | - Fenobam anhydrous
- Fenobam
- Fenobam monohydrate
- Fenobamum
- Fenobam hydrochloride
| | C11 H11 Cl N4 O2 | 266.684 | | 135413554 | 0 | 29 | 0 | 30 | 6 | 1 |
| D8B | 2-[2-(3-methoxyphenyl)ethynyl]-6-methyl-pyridine | | | C15 H13 N O | 223.27 | | 5311462 | 0 | 30 | 0 | 31 | 12 | 1 |
| AC5 | Cycloleucine | Cycloleucine hydrochloride | | C6 H11 N O2 | 129.157 | | 2901 | 0 | 20 | 0 | 20 | 0 | 1 |
| AIB | 2-aminoisobutyric acid | α-aminoisobutyric acid | | C4 H9 N O2 | 103.12 | | 5245672 | 0 | 16 | 0 | 15 | 0 | 39 |
| FUC | alpha-L-fucose | alpha-L-fucose; 6-deoxy-alpha-L-galactopyranose; L-fucose; fucose | | C6 H12 O5 | 164.156 | | 439554 | 0 | 23 | 5 | 23 | 0 | 2 |
| DOK | (2~{S})-2-(4-chlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one | | | C22 H24 Cl N O3 | 385.884 | | 132473033 | 0 | 51 | 1 | 54 | 12 | 1 |
| DO5 | (2~{R},3~{R})-2-(4-chlorophenyl)-3-oxidanyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one | | | C21 H22 Cl N O4 | 387.857 | | 132473034 | 0 | 49 | 2 | 52 | 12 | 1 |
| DNZ | (2~{R},3~{S})-3-azanyl-2-(4-chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one | | | C21 H23 Cl N2 O3 | 386.872 | | 132473035 | 0 | 50 | 2 | 53 | 12 | 1 |
| DNK | (2~{S})-3-methyl-2-phenyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one | | | C22 H25 N O3 | 351.439 | | 132473036 | 0 | 51 | 1 | 54 | 12 | 1 |
| DN5 | (2~{S})-2-(3,4-dichlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one | | | C22 H23 Cl2 N O3 | 420.329 | | 132473037 | 0 | 51 | 1 | 54 | 12 | 1 |
| DLH | 2-(4-chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-ethanone | | | C19 H18 Cl N O3 | 343.804 | | 132473038 | 0 | 42 | 0 | 45 | 12 | 1 |
| DLB | 3-[1'-[(2~{S})-2-(4-chlorophenyl)-3-methyl-butanoyl]spiro[1,3-benzodioxole-2,4'-piperidine]-5-yl]propanoic acid | | | C25 H28 Cl N O5 | 457.947 | | 132473039 | 0 | 60 | 1 | 63 | 12 | 1 |
| DL2 | 5-chloranyl-2-(2-oxidanylidene-2-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-ethyl)-3~{H}-pyridin-6-one | | | C18 H17 Cl N2 O4 | 360.792 | | 137349183 | 0 | 42 | 0 | 45 | 6 | 1 |
| EP5 | 2-[5-[2-[4-(4-cyanophenyl)piperazin-1-yl]-2-oxidanylidene-ethoxy]-1~{H}-indol-3-yl]ethylazanium | | | C23 H26 N5 O2 | 404.485 | | 137349273 | 1 | 56 | 0 | 59 | 16 | 2 |
| F7N | [(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5~{H}-1,6-naphthyridin-6-yl]carbonyl]cyclopentyl]azanium | | | C24 H35 F3 N3 O3 | 470.548 | | 53316397 | 1 | 68 | 4 | 71 | 6 | 2 |
| F9Q | Imaradenant | Imaradenant | | C15 H11 Cl F N5 | 315.733 | | 86676119 | 0 | 33 | 0 | 35 | 18 | 1 |
| FVK | ~{N}-[2-[[(2~{S})-2-oxidanyl-3-(4-oxidanylphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide | | | C16 H25 N3 O5 | 339.387 | | 12681891 | 0 | 49 | 1 | 50 | 6 | 1 |
| GBK | (2~{S},3~{S})-~{N}-[(2-methoxyphenyl)methyl]-2-phenyl-piperidin-3-amine | | | C19 H24 N2 O | 296.407 | | 5311057 | 0 | 46 | 2 | 48 | 12 | 1 |
| GBQ | Aprepitant | - Aprepitantum
- Aprepitant
- Aprépitant
| | C23 H21 F7 N4 O3 | 534.427 | | 135413536 | 0 | 58 | 3 | 61 | 12 | 3 |
| GAW | Netupitant | - 2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide
- Netupitant
| | C30 H32 F6 N4 O | 578.592 | | 6451149 | 0 | 73 | 0 | 76 | 18 | 1 |
| H98 | Arformoterol | - Arformoterol tartrate
- (-)-formoterol
- Arformoterol
- (R,R)-formoterol
| | C19 H24 N2 O4 | 344.405 | | 3083544 | 0 | 49 | 2 | 50 | 12 | 5 |
| SIN | Succinic acid | Succinic acid | | C4 H6 O4 | 118.088 | | 21952380 | 0 | 14 | 0 | 13 | 0 | 7 |
| A8X | Ramatroban | Ramatroban | | C21 H21 F N2 O4 S | 416.466 | | 123879 | 0 | 50 | 1 | 53 | 16 | 1 |
| A90 | 2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]ethanoic acid | Daltroban | | C16 H16 Cl N O4 S | 353.821 | | 54343 | 0 | 39 | 0 | 40 | 12 | 1 |
| L74 | 3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine | | | C18 H19 Cl N4 | 326.823 | | 3853 | 0 | 42 | 0 | 45 | 16 | 1 |
| D2U | (2~{S})-2-[[(2~{R})-2-[(3,5-dimethylphenyl)carbonyl-methyl-amino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid | | | C36 H35 N3 O4 | 573.681 | | 5311192 | 0 | 78 | 2 | 82 | 28 | 1 |
| CZX | Dexmedetomidine | Dexmedetomidinum | | C13 H16 N2 | 200.28 | | 5311068 | 0 | 31 | 1 | 32 | 11 | 8 |
| 8QX | 6-(4-bromanyl-2-fluoranyl-phenoxy)-2-methyl-3-[[(3~{S})-1-propan-2-ylpiperidin-3-yl]methyl]pyrido[3,2-d]pyrimidin-4-one | | | C23 H26 Br F N4 O2 | 489.381 | | 57400002 | 0 | 57 | 1 | 60 | 12 | 1 |
| 9GF | 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol | | | C24 H40 O3 | 376.573 | | 104895 | 0 | 67 | 3 | 68 | 6 | 7 |
| 9GL | 5-chloro-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indole-2-carboxamide | | | C24 H28 Cl N3 O | 409.952 | | 44828492 | 0 | 57 | 0 | 60 | 16 | 1 |
| E33 | (8~{a}~{R},12~{a}~{S},13~{a}~{R})-12-ethylsulfonyl-3-methoxy-5,6,8,8~{a},9,10,11,12~{a},13,13~{a}-decahydroisoquinolino[2,1-g][1,6]naphthyridine | | | C19 H28 N2 O3 S | 364.502 | | 57213234 | 0 | 53 | 3 | 56 | 6 | 2 |
| E3F | (8~{a}~{R},12~{a}~{S},13~{a}~{S})-12-ethylsulfonyl-3-methoxy-5,6,8,8~{a},9,10,11,12~{a},13,13~{a}-decahydroisoquinolino[2,1-g][1,6]naphthyridine | | | C19 H28 N2 O3 S | 364.502 | | 9908992 | 0 | 53 | 3 | 56 | 6 | 1 |
| E39 | (2~{S})-4-fluoranyl-2-(1~{H}-imidazol-5-yl)-1-propan-2-yl-2,3-dihydroindole | | | C14 H16 F N3 | 245.295 | | 145704643 | 0 | 34 | 1 | 36 | 11 | 1 |
| EBX | 4-[[3,4-bis(oxidanylidene)-2-[[(1~{R})-1-(4-propan-2-ylfuran-2-yl)propyl]amino]cyclobuten-1-yl]amino]-~{N},~{N}-dimethyl-3-oxidanyl-pyridine-2-carboxamide | | | C22 H26 N4 O5 | 426.466 | | 153466996 | 0 | 57 | 1 | 59 | 11 | 1 |
| EN6 | N-(2-hydroxyethyl)-5-(hydroxymethyl)-3-methyl-1-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzothiophen-7-yl]pyrazole-4-carboxamide | | | C24 H22 F3 N3 O3 S | 489.51 | | 69921479 | 0 | 56 | 0 | 59 | 21 | 3 |
| GMJ | Haloperidol | Haloperidol | | C21 H23 Cl F N O2 | 375.864 | | 3559 | 0 | 49 | 0 | 51 | 12 | 1 |
| QXV | D-methioninamide | | | C5 H12 N2 O S | 148.227 | | 11571827 | 0 | 21 | 1 | 20 | 0 | 5 |
| J9P | (11alpha,12alpha,13E,16S)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid | | | C21 H36 O5 | 368.508 | | 9820635 | 0 | 62 | 4 | 62 | 0 | 1 |
| JEV | Ramelteon | Ramelteon | | C16 H21 N O2 | 259.343 | | 208902 | 0 | 40 | 1 | 42 | 6 | 8 |
| JEY | N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide | 2-phenylmelatonin | | C19 H20 N2 O2 | 308.374 | | 4018512 | 0 | 43 | 0 | 45 | 16 | 5 |
| ML2 | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | | C13 H15 I N2 O2 | 358.175 | | 115348 | 0 | 33 | 0 | 34 | 10 | 3 |
| AWY | Agomelatine | | | C15 H17 N O2 | 243.301 | | 82148 | 0 | 35 | 0 | 36 | 11 | 1 |
| TYS | O-SULFO-L-TYROSINE | | | C9 H11 N O6 S | 261.252 | | 514186 | 0 | 28 | 1 | 28 | 6 | 22 |
| K5Y | salmeterol | 2-(hydroxymethyl)-4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl]phenol | | C25 H37 N O4 | 415.566 | | 6604001 | 0 | 67 | 1 | 68 | 12 | 1 |
| KBY | N-[(3R)-4-(4-tert-butylphenyl)-3-({2-[(4-methoxyphenyl)sulfanyl]-5-[methyl(propan-2-yl)sulfamoyl]benzene-1-carbonyl}amino)butanoyl]glycine | | | C34 H43 N3 O7 S2 | 669.851 | | 138454256 | 0 | 89 | 1 | 91 | 18 | 1 |
| KCA | methyl N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-3-methyl-L-valinate | | | C22 H24 F N3 O3 | 397.443 | | 119025665 | 0 | 53 | 1 | 55 | 16 | 5 |
| QUS | Quisqualic acid | QUISQUALATE | | C5 H7 N3 O5 | 189.126 | | 6971145 | 0 | 20 | 1 | 20 | 5 | 13 |
| LKD | 3-chloro-4,7-difluoro-N-{[2-methoxy-5-(pyridin-4-yl)phenyl]methyl}-N-[trans-4-(methylamino)cyclohexyl]-1-benzothiophene-2-carboxamide | | | C29 H28 Cl F2 N3 O2 S | 556.066 | | | 0 | 66 | 0 | 70 | 22 | 1 |
| M3J | 6-bromo-N~2~-phenylquinazoline-2,4-diamine | | | C14 H11 Br N4 | 315.168 | | 145998261 | 0 | 30 | 0 | 32 | 17 | 1 |
| N2V | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine | | | C50 H47 Cl2 N3 O6 | 856.831 | | 58327143 | 0 | 108 | 4 | 115 | 36 | 2 |
| CO1 | 17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL | 24,25(S)-EPOXYCHOLESTEROL | | C27 H44 O2 | 400.637 | | 3247059 | 0 | 73 | 9 | 77 | 0 | 4 |
| ODM | (3R)-3,7-dimethyloct-6-en-1-ol | citronellol | | C10 H20 O | 156.265 | | 101977 | 0 | 31 | 1 | 30 | 0 | 2 |
| 64Z | Geraniol | (2E)-3,7-dimethylocta-2,6-dien-1-ol | | C10 H18 O | 154.249 | | 637566 | 0 | 29 | 0 | 28 | 0 | 2 |
| NZZ | (2Z)-3,7-dimethylocta-2,6-dien-1-ol | nerol | | C10 H18 O | 154.249 | | 643820 | 0 | 29 | 0 | 28 | 0 | 2 |
| SNP | Dexpropranolol | (+)-Propranolol | | C16 H21 N O2 | 259.343 | | 91536 | 0 | 40 | 1 | 41 | 11 | 1 |
| WI5 | WIN 55212-2 | - WIN 55212-2 mesylate
- (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate
- WIN 55212-2
| | C27 H26 N2 O3 | 426.507 | | 5311501 | 0 | 58 | 1 | 63 | 21 | 2 |
| DAR | D-arginine | (2R)-2-amino-5-guanidinopentanoic acid | | C6 H15 N4 O2 | 175.209 | | 58433835 | 1 | 27 | 1 | 26 | 0 | 8 |
| OXJ | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine | | | C10 H9 F6 N | 257.176 | | 10956204 | 0 | 26 | 0 | 26 | 6 | 1 |
| OWY | 4-[(R)-[(2S,5R)-4-benzyl-2,5-dimethylpiperazin-1-yl](3-hydroxyphenyl)methyl]-N,N-diethylbenzamide | | | C31 H39 N3 O2 | 485.66 | | 58619550 | 0 | 75 | 3 | 78 | 18 | 1 |
| JLW | 3-[[4-[[(1~{R})-2,2-dimethyl-1-(5-methylfuran-2-yl)propyl]amino]-1,1-bis(oxidanylidene)-1,2,5-thiadiazol-3-yl]amino]-~{N},~{N},6-trimethyl-2-oxidanyl-benzamide | | | C22 H29 N5 O5 S | 475.561 | | 136165388 | 0 | 62 | 1 | 64 | 11 | 1 |
| KAZ | 2-[2-[[3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]phenyl]carbonylamino]phenyl]ethanoic acid | | | C27 H29 N3 O3 | 443.537 | | 138811017 | 0 | 62 | 0 | 65 | 18 | 1 |
| KNT | Pranlukast | - Pranlukast
- Pranlukast hydrate
| | C27 H23 N5 O4 | 481.503 | | 4887 | 0 | 59 | 0 | 63 | 23 | 1 |
| ZLK | Zafirlukast | - 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
- Zafirlukast
- cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate
| | C31 H33 N3 O6 S | 575.675 | | 5717 | 0 | 74 | 0 | 78 | 22 | 1 |
| KNW | (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | ONO-2570366 | | C30 H30 Cl F N2 O7 | 585.02 | | 145704683 | 0 | 71 | 1 | 74 | 18 | 2 |
| KNZ | (2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy]-2-fluoranyl-phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | ONO-2080365 | | C30 H29 F3 N2 O8 | 602.555 | | 145704684 | 0 | 72 | 1 | 75 | 18 | 1 |
| KO5 | (2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | ONO-2770372 | | C31 H33 F N2 O7 | 564.601 | | 145704685 | 0 | 74 | 1 | 77 | 18 | 1 |
| NRE | [(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]methyl]-5-methyl-piperidin-1-yl]-(3-fluoranyl-2-methoxy-phenyl)methanone | | | C20 H23 Br F N3 O2 | 436.318 | | 44463491 | 0 | 50 | 2 | 52 | 12 | 1 |
| NRK | Lemborexant | Lemborexant | | C22 H20 F2 N4 O2 | 410.417 | | 56944144 | 0 | 50 | 2 | 53 | 18 | 2 |
| NS2 | Daridorexant | - Nemorexant
- Daridorexant
- Daridorexant hydrochloride
- ACT-541468
| | C23 H23 Cl N6 O2 | 450.921 | | 91801202 | 0 | 55 | 1 | 59 | 21 | 1 |
| NRZ | (2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide | | | C20 H24 N2 O4 S | 388.481 | | 40924317 | 0 | 51 | 1 | 53 | 12 | 1 |
| NT5 | Filorexant | Filorexant | | C24 H25 F N4 O2 | 420.479 | | 25128145 | 0 | 56 | 2 | 59 | 18 | 1 |
| NU2 | Retosiban | Retosiban | | C27 H34 N4 O5 | 494.583 | | 11340891 | 0 | 70 | 4 | 74 | 11 | 1 |
| NU8 | 2-(5,6-dimethoxypyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one | | | C20 H15 F3 N4 O5 S | 480.417 | | 72707143 | 0 | 48 | 0 | 51 | 18 | 1 |
| NV8 | 2-[1-(phenylsulfonyl)-1,8-diazaspiro[4.5]decan-8-yl]-1,3-benzoxazole | | | C21 H23 N3 O3 S | 397.491 | | 16046844 | 0 | 51 | 0 | 55 | 16 | 1 |
| NVH | 2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one | | | C19 H13 F3 N4 O5 S2 | 498.456 | | 145714283 | 0 | 46 | 0 | 49 | 18 | 1 |
| NVK | 1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea | | | C17 H13 N5 O2 | 319.317 | | 6604926 | 0 | 37 | 0 | 40 | 21 | 1 |
| NVN | 1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4-(dimethylamino)phenyl]urea | | | C19 H18 F2 N4 O | 356.369 | | 4331799 | 0 | 44 | 0 | 46 | 17 | 1 |
| QD7 | (R)-(3-aminopropyl)methylphosphinic acid | | | C4 H12 N O2 P | 137.117 | | 5230 | 0 | 20 | 0 | 19 | 0 | 2 |
| QDA | N~4~,N~6~-dicyclopentyl-2-(methylsulfanyl)-5-nitropyrimidine-4,6-diamine | | | C15 H23 N5 O2 S | 337.44 | | 6604928 | 0 | 46 | 0 | 48 | 6 | 1 |
| JHC | [(2S)-2-[(2S)-butan-2-yl]-4-(5-chloro-1,3-benzoxazol-2-yl)-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | | | C26 H29 Cl N6 O2 | 493 | | 146675152 | 0 | 64 | 2 | 68 | 21 | 1 |
| QW7 | 1-[(1R)-1-(2,6-dichloro-3-methoxyphenyl)ethyl]-6-{2-[(2R)-piperidin-2-yl]phenyl}-1H-benzimidazole | | | C27 H27 Cl2 N3 O | 480.429 | | 146155955 | 0 | 60 | 2 | 64 | 22 | 2 |
| 08Y | Bromocriptine | 2-bromo-α-ergokryptine | | C32 H40 Br N5 O5 | 654.594 | | 31101 | 0 | 83 | 6 | 89 | 10 | 4 |
| 4J2 | (2R)-2-amino-3-(naphthalen-2-yl)propanoic acid | | | C13 H13 N O2 | 215.248 | | 2733661 | 0 | 29 | 1 | 30 | 11 | 10 |
| CA | CALCIUM ION | | | Ca | 40.078 | | | 2 | 1 | 0 | 0 | 0 | 53 |
| SGG | [(2~{S})-3-[[(1~{S})-1-(3,4-dichlorophenyl)ethyl]amino]-2-oxidanyl-propyl]-(phenylmethyl)phosphinic acid | | | C18 H22 Cl2 N O3 P | 402.252 | | 5311042 | 0 | 47 | 2 | 48 | 12 | 2 |
| U0G | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine | - 25CN-NBOH
- N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
- NBOH-2C-CN
| | C18 H20 N2 O3 | 312.363 | | 90489020 | 0 | 43 | 0 | 44 | 12 | 2 |
| U3G | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | | | C43 H76 N O8 P | 766.039 | | 52924645 | 0 | 129 | 1 | 128 | 0 | 1 |
| U3D | [(2R)-3-[(Z)-icos-11-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate | [(2~{R})-2-[(~{Z})-octadec-9-enoyl]oxy-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] (~{Z})-icos-11-enoate | | C46 H88 N O8 P | 814.167 | | 52923113 | 0 | 144 | 1 | 143 | 0 | 1 |
| OIN | Atropine | Atropine sulfate anhydrous | | C17 H23 N O3 | 289.369 | | | 0 | 44 | 3 | 46 | 6 | 1 |
| UK1 | 3-{(1S)-1-[5-(2,2-dimethylmorpholin-4-yl)-2-{(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carbonyl}-1H-indol-1-yl]butyl}-1,2,4-oxadiazol-5(4H)-one | | | C47 H49 F2 N11 O5 | 885.959 | | 154584718 | 0 | 114 | 2 | 123 | 31 | 2 |
| UK4 | PF-06882961 | PF-06882961 | | C31 H30 F N5 O4 | 555.599 | | 134611040 | 0 | 71 | 1 | 76 | 22 | 6 |
| V0S | 3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-{[3-(pyridin-4-yl)phenyl]methyl}-1-benzothiophene-2-carboxamide | | | C28 H28 Cl N3 O S | 490.059 | | | 0 | 62 | 0 | 66 | 22 | 3 |
| V6G | Orforglipron | - 1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dim
- Orforglipron
- 3-[(1S,2S)-1-({2-(4-fluoro-3,5-dimethylphenyl)-3-({3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}carbonyl)-5-[(4S)-2,2-dimethyloxan-4-yl]-1H-indol-1-yl}-2-methylcyc
| | C48 H48 F2 N10 O5 | 882.956 | | 137319706 | 0 | 113 | 4 | 123 | 31 | 4 |
| Q4T | 2-[2-[[3-[4-chloranyl-2-fluoranyl-5-[(3~{R})-piperidin-3-yl]oxy-phenyl]-2-fluoranyl-phenyl]carbonylamino]-5-fluoranyl-phenyl]ethanoic acid | | | C26 H22 Cl F3 N2 O4 | 518.912 | | 154585554 | 0 | 58 | 1 | 61 | 18 | 1 |
| Q6N | 2-[[5-(2,6-dimethoxyphenyl)-1-[4-[3-(dimethylamino)propyl-methyl-carbamoyl]-2-propan-2-yl-phenyl]pyrazol-3-yl]carbonylamino]adamantane-2-carboxylic acid | | | C39 H51 N5 O6 | 685.852 | | | 0 | 101 | 0 | 106 | 17 | 1 |
| Q6Q | 2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]adamantane-2-carboxylic acid | | | C32 H31 Cl N4 O5 | 587.065 | | | 0 | 73 | 0 | 79 | 22 | 3 |
| SR9 | (2~{S})-4-methyl-2-[(1-quinolin-8-ylsulfonylindol-3-yl)carbonylamino]pentanoic acid | | | C24 H23 N3 O5 S | 465.522 | | 155490996 | 0 | 56 | 1 | 59 | 21 | 1 |
| SR5 | (2~{S})-2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]-4-methyl-pentanoic acid | | | C27 H27 Cl N4 O5 | 522.98 | | 44157038 | 0 | 64 | 1 | 67 | 22 | 1 |
| QGE | [3-(4-methyl-1,3-thiazol-2-yl)-4-oxidanylidene-6-propyl-chromen-7-yl] ethanoate | | | C18 H17 N O4 S | 343.397 | | 740769 | 0 | 41 | 0 | 43 | 11 | 1 |
| QGW | [2-methyl-3-(4-methyl-1,3-thiazol-2-yl)-4-oxidanylidene-6-propyl-chromen-7-yl] ethanoate | | | C19 H19 N O4 S | 357.423 | | 984073 | 0 | 44 | 0 | 46 | 11 | 1 |
| QJT | 1-[3-(4-butylpiperidin-1-yl)propyl]-3,4-dihydroquinolin-2-one | | | C21 H32 N2 O | 328.492 | | 10236758 | 0 | 56 | 0 | 58 | 6 | 1 |
| QK8 | ethyl (4~{S})-4-[4-[(1-methylcyclobutyl)carbamoyl]piperidin-1-yl]azepane-1-carboxylate | | | C20 H35 N3 O3 | 365.51 | | 71528459 | 0 | 61 | 1 | 63 | 0 | 1 |
| QK2 | 7-fluoranyl-5-methyl-3-[1-(oxan-4-yl)piperidin-4-yl]-1~{H}-benzimidazol-2-one | | | C18 H24 F N3 O2 | 333.4 | | 16038386 | 0 | 48 | 0 | 51 | 6 | 1 |
| RVZ | 2-azanyl-6-(1~{H}-imidazol-2-ylmethylsulfanyl)-4-phenyl-pyridine-3,5-dicarbonitrile | | | C17 H12 N6 S | 332.382 | | 11174953 | 0 | 36 | 0 | 38 | 17 | 1 |
| DPN | D-Phenylalanine | D-Phenylalanine | | C9 H11 N O2 | 165.189 | | 71567 | 0 | 23 | 1 | 23 | 6 | 36 |
| CY3 | Cysteinamide | - 2-amino-3-mercapto-propionamide
- L-Cysteinamide
- Cysteinamide
| | C3 H8 N2 O S | 120.173 | | 6540253 | 0 | 15 | 1 | 14 | 0 | 2 |
| T0B | [(4~{a}~{R},8~{a}~{S})-4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)-2,3,4~{a},5,6,7,8,8~{a}-octahydroquinoxalin-1-yl]-(furan-2-yl)methanone | | | C23 H27 N5 O4 | 437.492 | | 132266 | 0 | 59 | 2 | 63 | 16 | 1 |
| F5O | Elagolix | | | C32 H30 F5 N3 O5 | 631.59 | | 11250647 | 0 | 75 | 1 | 78 | 18 | 1 |
| E5E | Noradrenaline | | | C8 H12 N O3 | 170.186 | | 6921840 | 1 | 24 | 1 | 24 | 6 | 6 |
| FFR | 2-[[4-[6-[(4-cyano-2-fluoranyl-phenyl)methoxy]pyridin-2-yl]-3,6-dihydro-2~{H}-pyridin-1-yl]methyl]-3-[[(2~{S})-oxetan-2-yl]methyl]imidazo[4,5-b]pyridine-5-carboxylic acid | | | C30 H27 F N6 O4 | 554.572 | | 149050799 | 0 | 68 | 1 | 73 | 22 | 2 |
| S1P | (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate | sphingosine 1-phosphate | | C18 H38 N O5 P | 379.472 | | 5283560 | 0 | 63 | 2 | 62 | 0 | 11 |
| 2C0 | Arbaclofen | (3R)-4-amino-3-(4-chlorophenyl)butanoic acid | | C10 H12 Cl N O2 | 213.661 | | 44602 | 0 | 26 | 1 | 26 | 6 | 3 |
| FN0 | (3S)-5,7-ditert-butyl-3-oxidanyl-3-(trifluoromethyl)-1-benzofuran-2-one | | | C17 H21 F3 O3 | 330.342 | | 7023848 | 0 | 44 | 1 | 45 | 6 | 4 |
| 2BV | (R)-(cyclohexylmethyl)[(2S)-3-{[(1S)-1-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropyl]phosphinic acid | CGP 54626 | | C18 H28 Cl2 N O3 P | 408.3 | | 197584 | 0 | 53 | 2 | 54 | 6 | 2 |
| FWX | 2-(ethylamino)-6-[3-(4-propan-2-ylphenyl)propanoyl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-4-carboxamide | | | C22 H29 N5 O2 | 395.498 | | 71541719 | 0 | 58 | 0 | 60 | 12 | 4 |
| FX0 | (2S,4R)-4-[(3R,5S,6R,7R,8R,9S,10S,12S,13R,14S,17R)-6-ethyl-10,13-dimethyl-3,7,12-tris(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-pentanoic acid | | | C27 H46 O5 | 450.651 | | 45483949 | 0 | 78 | 13 | 81 | 0 | 2 |
| G3C | (1R)-6-chloranyl-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | | | C16 H16 Cl N O3 | 305.756 | | 12668023 | 0 | 37 | 1 | 39 | 12 | 6 |
| G3O | (1R,3S)-3-(1-adamantyl)-1-(aminomethyl)-3,4-dihydro-1H-isochromene-5,6-diol | | | C20 H27 N O3 | 329.433 | | | 0 | 51 | 2 | 55 | 6 | 2 |
| G3U | 6-[4-[3-[bis(fluoranyl)methoxy]pyridin-2-yl]oxy-2-methyl-phenyl]-1,5-dimethyl-pyrimidine-2,4-dione | | | C19 H17 F2 N3 O4 | 389.353 | | 86764103 | 0 | 45 | 0 | 47 | 12 | 2 |
| LDP | Dopamine | 4-(2-Aminoethyl)benzene-1,2-diol | | C8 H11 N O2 | 153.178 | | 681 | 0 | 22 | 0 | 22 | 6 | 20 |
| G4C | Mevidalen | - 2-(2,6-dichlorophenyl)-1-((1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl)ethanone
- Ethanone, 2-(2,6-dichlorophenyl)-1-((1s,3r)-3,4-dihydro-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-2(1h)-isoquinolinyl)-
- Mevidalen
| | C24 H29 Cl2 N O3 | 450.398 | | 86290953 | 0 | 59 | 2 | 61 | 12 | 8 |
| G6L | Pramipexole | Pramipexol | | C10 H17 N3 S | 211.327 | | 119570 | 0 | 31 | 1 | 32 | 5 | 2 |
| G6O | (4aR,10bR)-4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol | | | C14 H19 N O3 | 249.306 | | 5311346 | 0 | 37 | 2 | 39 | 6 | 2 |
| GBU | (1S)-6-chloranyl-3-methyl-1-(3-methylphenyl)-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol | | | C18 H20 Cl N O2 | 317.81 | | 6604003 | 0 | 42 | 1 | 44 | 12 | 2 |
| GNO | Taprenepag | Taprenepag | | C24 H22 N4 O5 S | 478.52 | | 18376177 | 0 | 56 | 0 | 59 | 23 | 2 |
| GM9 | Evatanepag | - Evatanepag
- Evatanepag Sodium
| | C25 H28 N2 O5 S | 468.565 | | 9890801 | 0 | 61 | 0 | 63 | 18 | 2 |
| GXR | (8~{S},9~{R},10~{S},11~{S},13~{S},14~{S},16~{S},17~{R})-9-chloranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | | | C22 H29 Cl O5 | 408.916 | | 20469 | 0 | 57 | 8 | 60 | 0 | 2 |
| HCY | Hydrocortisone | Hydrocortisonum | | C21 H30 O5 | 362.46 | | 5754 | 0 | 56 | 7 | 59 | 0 | 2 |
| YP1 | NPS-2143 | NPS-2143 | | C24 H25 Cl N2 O2 | 408.921 | | 6918446 | 0 | 54 | 1 | 56 | 17 | 4 |
| H43 | Evocalcet | Evocalcet | | C24 H26 N2 O2 | 374.475 | | 71242808 | 0 | 54 | 2 | 57 | 17 | 2 |
| H46 | ~{N}-[4-[4-[(1~{S})-2-(diethylamino)-2-oxidanylidene-1-phenyl-ethyl]piperazin-1-yl]-3-fluoranyl-phenyl]-2-pyridin-3-yl-benzamide | | | C34 H36 F N5 O2 | 565.68 | | 25151875 | 0 | 78 | 1 | 82 | 24 | 1 |
| HSM | Histamine | 1H-Imidazole-4-ethanamine | | C5 H9 N3 | 111.145 | | 774 | 0 | 17 | 0 | 17 | 5 | 31 |
| SIP | Spiperone | Spiperone | | C23 H26 F N3 O2 | 395.47 | | 5265 | 0 | 55 | 0 | 58 | 12 | 1 |
| H6U | Mirabegron | Mirabegron | | C21 H24 N4 O2 S | 396.506 | | 9865528 | 0 | 52 | 1 | 54 | 17 | 2 |
| HNO | N-tert-butyl-6,7-bis(chloranyl)quinoxalin-2-amine | | | C12 H13 Cl2 N3 | 270.158 | | 156022738 | 0 | 30 | 0 | 31 | 11 | 8 |
| SRO | Serotonin | thrombotonin | | C10 H12 N2 O | 176.215 | | 5202 | 0 | 25 | 0 | 26 | 10 | 18 |
| 9SC | Aripiprazole | Aripiprazole | | C23 H27 Cl2 N3 O2 | 448.385 | | 60795 | 0 | 57 | 0 | 60 | 12 | 3 |
| HVU | 3-(1-methylpiperidin-4-yl)-1H-indol-5-ol | | | C14 H18 N2 O | 230.306 | | 2438 | 0 | 35 | 0 | 37 | 10 | 2 |
| TCR | CYCLOMETHYLTRYPTOPHAN | | | C12 H12 N2 O2 | 216.236 | | 449440 | 0 | 28 | 1 | 30 | 10 | 13 |
| PO4 | Phosphate ion | - Orthophosphate
- Phosphate ion
- Phosphate
| | O4 P | 94.971 | | 1061 | -3 | 5 | 0 | 4 | 0 | 28 |
| 40F | (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid | | | C8 H11 N O4 | 185.177 | | 213056 | 0 | 24 | 4 | 25 | 0 | 3 |
| HZR | JNJ-40411813 | JNJ-40411813 | | C20 H25 Cl N2 O | 344.878 | | 25195461 | 0 | 49 | 0 | 51 | 6 | 6 |
| J59 | Brimonidine | Brimonidine | | C11 H10 Br N5 | 292.135 | | 2435 | 0 | 27 | 0 | 29 | 11 | 2 |
| J5C | Oxymetazoline | Oxymetozoline | | C16 H24 N2 O | 260.375 | | 4636 | 0 | 43 | 0 | 44 | 6 | 4 |
| J5F | (1R,2R)-N-[(2S,3S)-2-azanyl-3-methyl-pentyl]-N-[4-(4-propylphenyl)phenyl]-2-pyridin-2-yl-cyclopropane-1-carboxamide | | | C30 H37 N3 O | 455.634 | | 58466521 | 0 | 71 | 4 | 74 | 18 | 2 |
| J89 | (2~{S})-2-azanyl-4-(4-octylphenyl)-2-[[oxidanyl-bis(oxidanylidene)-$l^{6}-phosphanyl]oxymethyl]butan-1-ol | | | C19 H34 N O5 P | 387.451 | | 11452022 | 0 | 60 | 1 | 60 | 6 | 6 |
| J8C | Siponimod | - Siponimod fumarate
- Siponimod
| | C29 H35 F3 N2 O3 | 516.595 | | 72959169 | 0 | 72 | 0 | 75 | 12 | 8 |
| J9R | 4-(1-methylpyrazol-4-yl)-7-[[(2~{S})-2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide | | | C20 H20 F3 N5 O2 | 419.4 | | 117641885 | 0 | 50 | 1 | 53 | 16 | 2 |
| J9U | (8~{R})-4-[2,4-bis(fluoranyl)phenyl]-8-methyl-7-[(2-methylpyrazol-3-yl)methyl]-6,8-dihydro-5~{H}-1,7-naphthyridine-2-carboxamide | | | C21 H21 F2 N5 O | 397.421 | | 155925951 | 0 | 50 | 1 | 53 | 17 | 1 |
| FME | N-Formylmethionine | - Formyl-methionine
- N-Formylmethionine
- N-formyl-L-methionine
- (2S)-2-(formylamino)-4-(methylthio)butanoic acid
- L-N-Formylmethionine
| | C6 H11 N O3 S | 177.221 | | 439750 | 0 | 22 | 1 | 21 | 0 | 16 |
| JER | Cenerimod | Cenerimod | | C25 H31 N3 O5 | 453.531 | | 49871973 | 0 | 64 | 1 | 67 | 17 | 2 |
| JEU | Ozanimod | - Ozanimodum
- Ozanimod
- Ozanimod hydrochloride
| | C23 H24 N4 O3 | 404.462 | | 52938427 | 0 | 54 | 1 | 57 | 17 | 2 |
| JF9 | N,N-dicyclohexyl-5-cyclopropyl-1,2-oxazole-3-carboxamide | | | C19 H28 N2 O2 | 316.438 | | 17253208 | 0 | 51 | 0 | 54 | 5 | 2 |
| JEX | 5-[4-phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole | | | C20 H10 F6 N2 O S | 440.362 | | 4077460 | 0 | 40 | 0 | 43 | 22 | 2 |
| 05X | Lasmiditan | - Lasmiditan
- Lasmiditan succinate
| | C19 H18 F3 N3 O2 | 377.36 | | 11610526 | 0 | 45 | 0 | 47 | 12 | 2 |
| MG | MAGNESIUM ION | | | Mg | 24.305 | | | 2 | 1 | 0 | 0 | 0 | 12 |
| GDP | Guanosine-5'-Diphosphate | Guanosine-5'-Diphosphate | | C10 H15 N5 O11 P2 | 443.201 | | 8977 | 0 | 43 | 4 | 45 | 5 | 16 |
| GTP | Guanosine-5'-Triphosphate | Guanosine-5'-Triphosphate | | C10 H16 N5 O14 P3 | 523.18 | | 135398633 | 0 | 48 | 4 | 50 | 5 | 86 |
| 1I8 | (3R)-N-[(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxidanylidene-propan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | | | C33 H41 Cl N6 O2 | 589.171 | | 9938402 | 0 | 83 | 2 | 88 | 17 | 2 |
| 1IB | PF-03654746 | PF-03654746 | | C18 H24 F2 N2 O | 322.393 | | | 0 | 47 | 0 | 49 | 6 | 1 |
| 1KQ | PF-5190457 | PF-5190457 | | C29 H32 N6 O S | 512.669 | | 58438464 | 0 | 69 | 1 | 75 | 21 | 1 |
| 1OE | Lintitript | Lintitript | | C20 H14 Cl N3 O3 S | 411.861 | | 122077 | 0 | 42 | 0 | 45 | 21 | 1 |
| NFA | Phenylalanylamide | - Phenylalanine amide
- (S)-2-amino-3-phenylpropanamide
- Phenylalaninamide
- L-phenylalanine amide
- Phenylalanylamide
| | C9 H12 N2 O | 164.204 | | 445694 | 0 | 24 | 1 | 24 | 6 | 6 |
| SMF | 4-SULFOMETHYL-L-PHENYLALANINE | | | C10 H13 N O5 S | 259.279 | | 11010698 | 0 | 30 | 1 | 30 | 6 | 1 |
| OEM | N-methyl-D-aspartic acid | | | C5 H9 N O4 | 147.129 | | 22880 | 0 | 19 | 1 | 18 | 0 | 1 |
| NH2 | AMINO GROUP | | | H2 N | 16.023 | | 123329 | 0 | 3 | 0 | 2 | 0 | 130 |
| 1OZ | N-[(3S)-1-methyl-2-oxidanylidene-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | | | C25 H20 N4 O2 | 408.452 | | 443375 | 0 | 51 | 1 | 55 | 22 | 1 |
| OCA | Caprylic acid | ácido octanoico | | C8 H16 O2 | 144.211 | | 379 | 0 | 26 | 0 | 25 | 0 | 4 |
| DHI | D-HISTIDINE | | | C6 H10 N3 O2 | 156.162 | | 5460937 | 1 | 21 | 1 | 21 | 5 | 2 |
| DTR | D-Tryptophan | - D-Tryptophan
- (2R)-2-amino-3-(1H-indol-3-yl)propanoic acid
- (R)-tryptophan
- DTR
| | C11 H12 N2 O2 | 204.225 | | 6923517 | 0 | 27 | 1 | 28 | 10 | 32 |
| DLY | D-Lysine | - D-Lysine
- D-Lysin
- D-2,6-Diaminohexanoic acid
- (R)-2,6-diaminohexanoic acid
| | C6 H14 N2 O2 | 146.188 | | 57449 | 0 | 24 | 1 | 23 | 0 | 2 |
| Z99 | 2-[(1S,2S)-2-carboxycyclopropyl]-3-(9H-xanthen-9-yl)-D-alanine | (1S,2S)-2-[(2S)-2-amino-1-hydroxy-1-oxo-3-(9H-xanthen-9-yl)propan-2-yl]cyclopropane-1-carboxylic acid | | C20 H19 N O5 | 353.369 | | 9819927 | 0 | 45 | 3 | 48 | 12 | 13 |
| 7IC | 6-methyl-3-[(1S)-2-nitro-1-thiophen-2-yl-ethyl]-2-phenyl-1H-indole | | | C21 H18 N2 O2 S | 362.445 | | 129407013 | 0 | 44 | 1 | 47 | 21 | 3 |
| CMS | CARBAMOYL SARCOSINE | | | C4 H8 N2 O3 | 132.118 | | 439375 | 0 | 17 | 0 | 16 | 0 | 4 |
| LMS | [(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate | [(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate | | C10 H14 N6 O6 S | 346.32 | | 97576 | 0 | 37 | 4 | 39 | 10 | 4 |
| TMR | 2,6-dideoxy-4-S-methyl-4-thio-beta-D-ribo-hexopyranose | 2,6-DIDEOXY-4-THIOMETHYL-BETA-D-RIBOHEXOPYRANOSIDE; 2,6-dideoxy-4-S-methyl-4-thio-beta-D-ribo-hexose; 2,6-dideoxy-4-S-methyl-4-thio-D-ribo-hexose; 2,6-dideoxy-4-S-methyl-4-thio-ribo-hexose | | C7 H14 O3 S | 178.249 | | 447846 | 0 | 25 | 4 | 25 | 0 | 4 |
| GLM | | | | | | | | | | | | | 4 |
| 55Z | 5-azanyl-N-tert-butyl-2-methylsulfanyl-4-[3-(2-morpholin-4-ylethanoylamino)phenyl]thieno[2,3-d]pyrimidine-6-carboxamide | | | C24 H30 N6 O3 S2 | 514.663 | | 9914457 | 0 | 65 | 0 | 68 | 16 | 2 |
| GGL | Glutamic acid | Glutamic acid | | C5 H9 N O4 | 147.129 | | 44272391 | 0 | 19 | 1 | 18 | 0 | 12 |
| VFD | Olodanrigan | EMA401; (3S)-5-(benzyloxy)-2-(diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | | C32 H29 N O5 | 507.576 | | 9937291 | 0 | 67 | 1 | 71 | 24 | 1 |
| VFP | 6-{4-[(furo[3,2-c]pyridin-4-yl)oxy]-2-methylphenyl}-1,5-dimethylpyrimidine-2,4(1H,3H)-dione | | | C20 H17 N3 O4 | 363.367 | | 75202022 | 0 | 44 | 0 | 47 | 16 | 2 |
| SK0 | (1R)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | | | C16 H16 Cl N O2 | 289.757 | | 12668019 | 0 | 36 | 1 | 38 | 12 | 4 |
| SK9 | (1R)-6-chloro-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | | | C18 H20 Cl N O2 | 317.81 | | 9995976 | 0 | 42 | 1 | 44 | 12 | 2 |
| OR9 | Apomorphine | Apomorphine | | C17 H17 N O2 | 267.322 | | 6005 | 0 | 37 | 1 | 40 | 12 | 2 |
| VRJ | N-(tert-butylsulfonyl)-4-fluoro-2-{(3S,4R)-4-hydroxy-3-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1-benzopyran-7-yl}benzamide | | | C26 H27 F N2 O5 S | 498.566 | | 129208412 | 0 | 62 | 2 | 65 | 18 | 1 |
| WF1 | 17-amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oic acid | | | C12 H24 N2 O7 | 308.328 | | 51340918 | 0 | 45 | 0 | 44 | 0 | 2 |
| XGD | 4'-methoxy-N,N-dimethyl-3'-{[3-(2-{[2-(2H-1,2,3-triazol-2-yl)benzene-1-carbonyl]amino}ethyl)phenyl]sulfamoyl}[1,1'-biphenyl]-3-carboxamide | | | C33 H32 N6 O5 S | 624.709 | | 155491009 | 0 | 77 | 0 | 81 | 29 | 2 |
| XTD | {2-amino-4-[3,5-bis(trifluoromethyl)phenyl]thiophen-3-yl}(4-chlorophenyl)methanone | | | C19 H10 Cl F6 N O S | 449.797 | | 25263603 | 0 | 39 | 0 | 41 | 17 | 2 |
| YP4 | Cinacalcet | - (R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
- Cinacalcet
- Cinacalcet hydrochloride
- CNC
- N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
| | C22 H22 F3 N | 357.412 | | 156419 | 0 | 48 | 1 | 50 | 17 | 9 |
| ACE | ACETYL GROUP | | | C2 H4 O | 44.053 | | 177 | 0 | 7 | 0 | 6 | 0 | 20 |
| DCY | D-Cysteine | D-Zystein | | C3 H7 N O2 S | 121.158 | | 6419721 | 0 | 14 | 1 | 13 | 0 | 4 |
| YSS | 15R-methyl-prostaglandin D2 | (5Z,13E,15R,16E)-9alpha,15-dihydroxy-15-methyl-11-oxo-12alpha-prosta-5,13,16-trien-1-oic acid | | C21 H34 O5 | 366.492 | | 5283097 | 0 | 60 | 4 | 60 | 0 | 1 |
| ZQY | 2-methoxy-6-propyl-N-(2-{4-[(1H-tetrazol-5-yl)methoxy]phenyl}ethyl)thieno[2,3-d]pyrimidin-4-amine | | | C20 H23 N7 O2 S | 425.507 | | 11669059 | 0 | 53 | 0 | 56 | 21 | 3 |
| 1IC | O-octanoyl-D-serine | | | C11 H21 N O4 | 231.289 | | 162368291 | 0 | 37 | 1 | 36 | 0 | 2 |
| 1KD | Ibutamoren | - 2-amino-n-((r)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methylpropionamide
- Ibutamoren mesylate
- Ibutamoren
- 2-amino-n-(3-(benzyloxy)-1-(1-methanesulfonyl-1,2-dihydrospiro(indole-3,4'-piperidin)-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide
| | C27 H36 N4 O5 S | 528.664 | | 178024 | 0 | 73 | 1 | 76 | 12 | 2 |
| 4YI | 2-chloranyl-~{N}-[2-methoxy-4-[(~{E})-pyridin-2-yldiazenyl]phenyl]benzamide | | | C19 H15 Cl N4 O2 | 366.801 | | | 0 | 41 | 0 | 43 | 18 | 2 |
| 7Y5 | Selatogrel | [(2~{R})-3-(4-butoxycarbonylpiperazin-1-yl)-2-[[6-[(3~{S})-3-methoxypyrrolidin-1-yl]-2-phenyl-pyrimidin-4-yl]carbonylamino]-3-oxidanylidene-propyl]phosphonic acid; [(2R)-3-(4-butoxycarbonylpiperazin-1-yl)-2-[[6-[(3S)-3-methoxypyrrolidin-1-yl]-2-phenyl-pyrimidin-4-yl]carbonylamino]-3-oxidanylidene-propyl]phosphonic acid; 4-((R)-2-((6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)-3-phosphonopropionyl)piperazine-1-carboxylic acid butyl ester | | C28 H39 N6 O8 P | 618.618 | | 59534142 | 0 | 82 | 2 | 85 | 12 | 1 |
| 8E2 | Preladenant conjugate PSB-2113 | ~{tert}-butyl 2-[2-[2-[2-[2-[2-[4-[4-[2-[7-azanyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl]piperazin-1-yl]phenoxy]ethanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethanoate | | C38 H52 N10 O9 | 792.881 | | 162677683 | 0 | 109 | 0 | 114 | 25 | 1 |
| 8IM | 2-[2-[2-[2-[2-[2-[4-[4-[2-[7-azanyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl]piperazin-1-yl]phenoxy]ethanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]-~{N}-[5-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-1,3-diaza-2$l^{4}-boratricyclo[7.3.0.0^{3,7}]dodeca-4,6,9,11-tetraen-8-yl]pentyl]ethanamide | | | C52 H68 B F2 N13 O8 | 1,051.986 | | 162677684 | 0 | 144 | 0 | 152 | 30 | 1 |
| 3IQ | (3R)-3-methyl-5-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,2,3,6-tetrahydropyridin-1-ium | | | C13 H16 N3 | 214.286 | | 164575847 | 1 | 32 | 1 | 34 | 10 | 2 |
| 41Y | 2-fluoro-4-[(1R)-6-methoxy-1-methyl-2-{(1S)-1-[4-(propan-2-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolin-5-yl]-6-[(2-methylpropyl)amino]phenol | | | C32 H41 F N2 O2 | 504.679 | | 163183774 | 0 | 78 | 2 | 81 | 18 | 2 |
| 82L | 2-[(4-{6-[(2,4-difluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid | | | C32 H32 F2 N6 O3 | 586.632 | | 134611223 | 0 | 75 | 0 | 80 | 27 | 1 |
| 8IU | (3R)-N,N-dimethyl-1-[(8S)-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-3-amine | | | C18 H21 N5 | 307.393 | | 95882507 | 0 | 44 | 1 | 47 | 16 | 4 |
| 8IX | N-[(1r,3R,5S,7R)-3,5-dimethyltricyclo[3.3.1.1~3,7~]decane-1-carbonyl]-D-phenylalanine | | | C22 H29 N O3 | 355.471 | | | 0 | 55 | 3 | 58 | 6 | 2 |
| 8QY | PZM21 | PZM21 | | C19 H27 N3 O2 S | 361.502 | | 121596705 | 0 | 52 | 2 | 53 | 11 | 4 |
| 8RI | (2E)-N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-(naphthalen-1-yl)prop-2-enamide | | | C24 H26 N2 O2 | 374.475 | | 162745306 | 0 | 54 | 1 | 56 | 17 | 2 |
| 9IG | 3-(2-chlorophenyl)-N-[(1R)-1-(3-methoxyphenyl)ethyl]propan-1-amine | | | C18 H22 Cl N O | 303.826 | | 158797 | 0 | 43 | 1 | 44 | 12 | 11 |
| GJ9 | (1R)-4-[7-(3-carboxypropoxy)-6-methylquinolin-8-yl]-1-{[2-(4-hydroxypiperidin-1-yl)-1,3-thiazol-4-yl]methyl}-1,4-diazepan-1-ium | | | C28 H38 N5 O4 S | 540.697 | | 164575505 | 1 | 76 | 0 | 80 | 16 | 3 |
| A6F | Danavorexton | - Methyl (2R,3S)-3-[(Methylsulfonyl)Amino]-2-{[(Cis-4-Phenylcyclohexyl)Oxy]Methyl}Piperidine-1-Carboxylate
- 1-piperidinecarboxylic acid, 3-((methylsulfonyl)amino)-2-(((cis-4-phenylcyclohexyl)oxy)methyl)-, methyl ester, (2r,3s)-
- Methyl (2r,3s)-3-((methylsulfonyl)amino)-2-(((cis-4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate
- Danavorexton
| | C21 H32 N2 O5 S | 424.554 | | | 0 | 61 | 2 | 63 | 6 | 4 |
| 8EH | (1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyridin-2-yl)-1,2,4-triazol-3-yl]-1-(5-methylpyrimidin-2-yl)-1-oxidanyl-propane-2-sulfonamide | | | C24 H27 N7 O5 S | 525.58 | | 122701908 | 0 | 64 | 2 | 67 | 23 | 5 |
| THO | L-Threoninol | L-Threoninol | | C4 H11 N O2 | 105.136 | | 2033049 | 0 | 18 | 2 | 17 | 0 | 4 |
| EIG | Mitragynine pseudoindoxyl | methyl (2E)-4-[(2S,2'S)-1'-butyl-4-methoxy-3-oxo-1,3-dihydrospiro[indole-2,3'-pyrrolidin]-2'-yl]-2-(methoxymethylidene)butanoate | | C23 H30 N2 O5 | 414.495 | | 44301701 | 0 | 60 | 4 | 63 | 6 | 2 |
| EID | Lofentanil | methyl (3R,4S)-3-methyl-1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate | | C25 H32 N2 O3 | 408.533 | | 10070040 | 0 | 62 | 2 | 64 | 12 | 2 |
| FUI | N-(4-chlorophenyl)-N'-[1-methyl-3-oxo-2-phenyl-5-(propan-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]urea | | | C20 H21 Cl N4 O2 | 384.859 | | 24776341 | 0 | 48 | 0 | 50 | 12 | 2 |
| ACH | Acetylcholine | - Choline acetate
- O-Acetylcholine
- Acetylcholine
- Acetylcholine chloride
- ACh
| | C7 H16 N O2 | 146.207 | | 187 | 1 | 26 | 0 | 25 | 0 | 10 |
| Z41 | (2S)-3-hydroxypropane-1,2-diyl dihexadecanoate | | | C35 H68 O5 | 568.911 | | 644078 | 0 | 108 | 1 | 107 | 0 | 4 |
| NKP | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate | 18:1 LPA; oleoyl lysophosphatidic acid | | C21 H41 O7 P | 436.52 | | 49837858 | 0 | 70 | 1 | 69 | 0 | 16 |
| IUE | 3-amino-5-chloro-N-cyclopropyl-6-methoxy-4-methylthieno[2,3-b]pyridine-2-carboxamide | | | C13 H14 Cl N3 O2 S | 311.787 | | 11536903 | 0 | 34 | 0 | 36 | 10 | 2 |
| IUI | 5-amino-3,4-dimethyl-N-{[4-(trifluoromethanesulfonyl)phenyl]methyl}thieno[2,3-c]pyridazine-6-carboxamide | | | C17 H15 F3 N4 O3 S2 | 444.451 | | 73774630 | 0 | 44 | 0 | 46 | 16 | 2 |
| KKF | 8-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-3-[(3,4-dichlorophenyl)methyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one | | | C23 H21 Cl3 N2 O3 | 479.783 | | 126843232 | 0 | 52 | 0 | 55 | 12 | 1 |
| KJX | (2S,4aS,4bS,7R,8S,8aS,9R,10aR)-7-[(2R,3R)-7-hydroxy-3,7-dimethyloctan-2-yl]-4a,7,8-trimethyltetradecahydrophenanthrene-2,9-diol | | | C27 H46 O3 | 418.652 | | 11954197 | 0 | 76 | 9 | 79 | 0 | 2 |
| KZR | N-(6-carbamimidamidohexyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | | | C23 H39 N5 O | 401.589 | | 10363696 | 0 | 68 | 0 | 69 | 6 | 2 |
| L0X | N-(5-carbamimidamidopentyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | | | C22 H37 N5 O | 387.562 | | 163201242 | 0 | 65 | 0 | 66 | 6 | 2 |
| FO9 | famotidine | | | C8 H17 N7 O2 S3 | 339.461 | | | 0 | 37 | 0 | 37 | 0 | 1 |
| NG0 | Alvimopan | Alvimopan | | C25 H32 N2 O4 | 424.533 | | 5488548 | 0 | 63 | 3 | 65 | 12 | 1 |
| NN6 | ~{N}-[azanyl(azanylidene)methylidene]-5-fluoranyl-8-[2,4,6-tris(fluoranyl)phenyl]-3,4-dihydro-1~{H}-isoquinoline-2-carboxamide | | | C17 H14 F4 N4 O | 366.313 | | 60152964 | 0 | 40 | 0 | 42 | 12 | 1 |
| 8K3 | 3-(2-azanylethyl)-1H-indole-5-carboxamide | | | C11 H13 N3 O | 203.24 | | 1809 | 0 | 28 | 0 | 29 | 10 | 6 |
| D6M | N-hexadecanoyl-L-glutamic acid | | | C21 H39 N O5 | 385.538 | | 161955 | 0 | 66 | 1 | 65 | 0 | 16 |
| 5XI | methyl 4-[4-(3-methyl-2-oxidanylidene-benzimidazol-1-yl)piperidin-1-yl]piperidine-1-carboxylate | | | C20 H28 N4 O3 | 372.461 | | 9864275 | 0 | 55 | 0 | 58 | 6 | 2 |
| 6IB | 2-[4-methoxy-3-[[2-methoxy-3-[[2-methoxy-5-[2-(methylamino)ethyl]phenyl]methyl]-5-[2-(methylamino)ethyl]phenyl]methyl]phenyl]-~{N}-methyl-ethanamine | | | C32 H45 N3 O3 | 519.718 | | 2855 | 0 | 83 | 0 | 85 | 18 | 5 |
| TYC | L-tyrosinamide | - L-tyrosinamide
- (2S)-2-amino-3-(4-hydroxyphenyl)propanamide
- L-Tyrosine amide
- Tyrosinamide
- Tyrosine amide
| | C9 H12 N2 O2 | 180.204 | | 151243 | 0 | 25 | 1 | 25 | 6 | 12 |
| 7I4 | 1-[[2-fluoranyl-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]azetidine-3-carboxylic acid | | | C23 H24 F N3 O3 | 409.453 | | 117972004 | 0 | 54 | 0 | 57 | 17 | 4 |
| LTB | Leukotriene B4 | | | C20 H32 O4 | 336.466 | | 5280492 | 0 | 56 | 2 | 55 | 0 | 2 |
| 7RU | Cariprazine | Cariprazine | | C21 H32 Cl2 N4 O | 427.411 | | | 0 | 60 | 0 | 62 | 6 | 1 |
| 7ZQ | 3-chloranyl-N-[2-oxidanylidene-2-[[(1S)-1-phenylethyl]amino]ethyl]benzamide | | | C17 H17 Cl N2 O2 | 316.782 | | 2548547 | 0 | 39 | 1 | 40 | 12 | 8 |
| K4Q | [(2~{S})-2-azanyl-3-oxidanylidene-propyl] octanoate | | | C11 H21 N O3 | 215.289 | | 155312307 | 0 | 36 | 1 | 35 | 0 | 2 |
| BAL | beta-Alanine | ω-aminopropionic acid | | C3 H7 N O2 | 89.093 | | 4755801 | 0 | 13 | 0 | 12 | 0 | 7 |
| NLN | NORLEUCINE AMIDE | 2-AMINO-HEXANOIC ACID AMIDE | | C6 H14 N2 O | 130.188 | | 445699 | 0 | 23 | 1 | 22 | 0 | 2 |
| 8B8 | (2S)-3-(1H-indol-3-yl)-N-[[1-(5-methoxypyridin-2-yl)cyclohexyl]methyl]-2-methyl-2-[(4-nitrophenyl)carbamoylamino]propanamide | | | C32 H36 N6 O5 | 584.665 | | 9829828 | 0 | 79 | 1 | 83 | 22 | 1 |
| W96 | N-pyridin-4-ylisoquinolin-4-amine | | | C14 H11 N3 | 221.257 | | 164946675 | 0 | 28 | 0 | 30 | 17 | 2 |
| W58 | 5-(3-bicyclo[4.2.0]octa-1,3,5-trienyl)-1,2,3,6-tetrahydropyridine | | | C13 H15 N | 185.265 | | 164946676 | 0 | 29 | 0 | 31 | 6 | 2 |
| 91Q | 3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-ol | | | C12 H16 N2 O | 204.268 | | 4980 | 0 | 31 | 0 | 32 | 10 | 4 |
| 92S | Lumateperone | lumateperone | | C24 H28 F N3 O | 393.497 | | 21302490 | 0 | 57 | 2 | 61 | 12 | 1 |
| 93F | (10~{R},15~{S})-12-[3-(2-methoxyphenyl)propyl]-4-methyl-1,4,12-triazatetracyclo[7.6.1.0^{5,16}.0^{10,15}]hexadeca-5(16),6,8-triene | | | C24 H31 N3 O | 377.522 | | 162421364 | 0 | 59 | 2 | 63 | 12 | 1 |
| 8VP | MBX-2982 | MBX-2982 | | C22 H24 N8 O S | 448.544 | | 25025505 | 0 | 56 | 0 | 60 | 22 | 4 |
| 8WL | N-(2-fluoranyl-4-methylsulfonyl-phenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine | AR231453 | | C21 H24 F N7 O5 S | 505.523 | | 24939268 | 0 | 59 | 0 | 62 | 17 | 2 |
| 9FI | ~{N}-[(2~{R})-1-[[(1~{R},3~{S})-3-(aminomethyl)cyclohexyl]methylamino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]spiro[indene-1,4'-piperidine]-1'-carboxamide | | | C33 H41 N5 O2 | 539.711 | | 9915239 | 0 | 81 | 3 | 86 | 16 | 2 |
| CWY | (1S,2S,4S,5R,6S)-2-amino-4-[(3-methoxybenzene-1-carbonyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic acid | | | C16 H18 N2 O6 | 334.324 | | 60096231 | 0 | 42 | 5 | 44 | 6 | 1 |
| LPD | L-PROLINAMIDE | | | C5 H10 N2 O | 114.146 | | 111306 | 0 | 18 | 1 | 18 | 0 | 2 |
| K6G | [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] hexadecanoate | | | C24 H51 N O7 P | 496.638 | | | 0 | 84 | 1 | 83 | 0 | 6 |
| 4PH | 4-methyl-L-phenylalanine | | | C10 H13 N O2 | 179.216 | | 6992323 | 0 | 26 | 1 | 26 | 6 | 2 |
| RGI | METHYLCARBAMIC ACID | | | C2 H5 N O2 | 75.067 | | 30536 | 0 | 10 | 0 | 9 | 0 | 2 |
| 86W | Tavapadon | Tavapadon | | C19 H16 F3 N3 O3 | 391.344 | | 86764100 | 0 | 44 | 0 | 46 | 12 | 2 |
| BYI | 2,4-bis(3-methoxy-4-thiophen-2-ylcarbonyloxy-phenyl)-1,3-bis[[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]carbonylamino]cyclobutane-1,3-dicarboxylic acid | | | C54 H52 N4 O16 S2 | 1,077.138 | | | 0 | 128 | 0 | 134 | 34 | 2 |
| WB2 | 2,4-bis(3-methoxy-4-thiophen-2-ylcarbonyloxy-phenyl)-1,3-bis[[4-(2-methylpropanoylamino)phenyl]carbonylamino]cyclobutane-1,3-dicarboxylic acid | | | C52 H48 N4 O14 S2 | 1,017.086 | | | 0 | 120 | 2 | 126 | 34 | 2 |
| EI5 | 3-[3-[2-[[(2~{S})-2-(3-chlorophenyl)-2-oxidanyl-ethyl]amino]ethylamino]phenyl]benzoic acid | | | C23 H23 Cl N2 O3 | 410.893 | | 67469417 | 0 | 52 | 1 | 54 | 18 | 2 |
| FI7 | 2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2,4-oxadiazol-5-yl]propanoyl]amino]cyclohexene-1-carboxylic acid | | | C19 H22 N4 O5 | 386.402 | | 135416394 | 0 | 50 | 0 | 52 | 11 | 14 |
| GJ6 | (5R,6R)-6-(propan-2-ylamino)-5,6,7,8-tetrahydronaphthalene-1,2,5-triol | | | C13 H19 N O3 | 237.295 | | 12353629 | 0 | 36 | 2 | 37 | 6 | 1 |
| G1I | (5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2,5-triol | | | C11 H15 N O3 | 209.242 | | 12353638 | 0 | 30 | 2 | 31 | 6 | 137 |
| AND | Prasterone | Dehydroepiandrosterone | | C19 H28 O2 | 288.424 | | 5881 | 0 | 49 | 6 | 52 | 0 | 8 |
| I8B | (2~{S})-2-[[(2~{S})-4-azanyl-2-[(4-methylnaphthalen-1-yl)sulfonylamino]butanoyl]amino]-3-phenyl-propanimidic acid | | | C24 H28 N4 O4 S | 468.569 | | 11442741 | 0 | 61 | 2 | 63 | 17 | 2 |
| GI9 | tert-butyl (2S)-6-azanyl-2-[[(2R,3S)-3-(1H-indol-3-yl)-2-[[4-(2-oxidanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]carbonylamino]butanoyl]amino]hexanoate | L-054,52 | | C35 H47 N7 O5 | 645.792 | | 15965425 | 0 | 94 | 3 | 98 | 16 | 1 |
| PPN | PARA-NITROPHENYLALANINE | | | C9 H10 N2 O4 | 210.187 | | 13706 | 0 | 25 | 1 | 25 | 6 | 1 |
| DTY | D-Tyrosine | - (R)-2-Amino-3-(p-hydroxyphenyl)propionic acid
- (R)-3-(p-Hydroxyphenyl)alanine
- D-Tyr
- D-Tyrosin
- D-Tyrosine
| | C9 H11 N O3 | 181.189 | | 71098 | 0 | 24 | 1 | 24 | 6 | 9 |
| IA1 | 2-[2-[[4-(4-chloranyl-2,5-dimethoxy-phenyl)-5-(2-cyclohexylethyl)-1,3-thiazol-2-yl]carbamoyl]-5,7-dimethyl-indol-1-yl]ethanoic acid | | | C32 H36 Cl N3 O5 S | 610.163 | | 9852833 | 0 | 78 | 0 | 82 | 21 | 2 |
| SY9 | Strychnine | Strychnidin-10-one | | C21 H22 N2 O2 | 334.412 | | 441071 | 0 | 47 | 7 | 53 | 6 | 2 |
| H8I | [2-(2,5-Dichloro-phenoxy)-pyridin-3-yl]-(3,4-dihydro-2H-quinolin-1-yl)-methanone | | | C21 H16 Cl2 N2 O2 | 399.27 | | 46195848 | 0 | 43 | 0 | 46 | 18 | 2 |
| WJS | (2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid | | | C24 H20 N O9 P | 497.391 | | | 0 | 55 | 2 | 54 | 0 | 4 |
| HOI | ~{N}-[4-[[2-methoxy-5-[(2~{S})-5-oxidanyl-4-oxidanylidene-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]ethanamide | | | C31 H29 N3 O5 | 523.579 | | 118685720 | 0 | 68 | 1 | 72 | 24 | 4 |
| I5D | 2-[6-azanyl-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl]sulfanylethanamide | | | C19 H17 N5 O2 S | 379.436 | | 11717831 | 0 | 44 | 0 | 46 | 12 | 4 |
| LSC | (4R,7R,18E)-4,7-dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium 4-oxide | | | C26 H53 N O7 P | 522.675 | | 5313986 | 1 | 88 | 1 | 87 | 0 | 2 |
| I7J | propan-2-yl 4-[1-(2-fluoranyl-4-methylsulfonyl-phenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate | | | C21 H24 F N5 O5 S | 477.509 | | 11705608 | 0 | 57 | 0 | 60 | 16 | 2 |
| OH | Hydroxide ion | - Hydroxide ion
- Hydroxide
- Oxidanide
| | H O | 17.007 | | 961 | -1 | 2 | 0 | 1 | 0 | 2 |
| IUD | Paltusotine | 3-[4-(4-azanylpiperidin-1-yl)-3-[3,5-bis(fluoranyl)phenyl]quinolin-6-yl]-2-oxidanyl-benzenecarbonitrile | | C27 H22 F2 N4 O | 456.487 | | 134168328 | 0 | 56 | 0 | 60 | 23 | 2 |
| ITF | 2-(1~{H}-imidazol-5-yl)ethyl carbamimidothioate | | | C6 H10 N4 S | 170.235 | | 3692 | 0 | 21 | 0 | 21 | 5 | 6 |
| IVB | Nalfurafine | ~{N}-[(4~{R},4~{a}~{S},7~{R},7~{a}~{R},12~{b}~{S})-3-(cyclopropylmethyl)-4~{a},9-bis(oxidanyl)-1,2,4,5,6,7,7~{a},13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-~{N}-methyl-propanamide | | C28 H32 N2 O5 | 476.564 | | 6445230 | 0 | 67 | 5 | 73 | 11 | 1 |
| IYF | 1-[2-(4-chlorophenyl)ethyl]-3-[(7-ethyl-5-oxidanyl-1H-indol-3-yl)methylideneamino]guanidine | | | C20 H22 Cl N5 O | 383.875 | | 138319674 | 0 | 49 | 0 | 51 | 16 | 4 |
| IYM | [(1S)-7-ethoxy-6-methoxy-1-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-morpholin-4-yl-methanone | | | C28 H35 N3 O5 | 493.595 | | 166625060 | 0 | 71 | 1 | 75 | 16 | 2 |
| JGX | Tamsulosin | (R)-(−)-tamsulosin | | C20 H28 N2 O5 S | 408.512 | | 129211 | 0 | 56 | 1 | 57 | 12 | 1 |
| K6L | [(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate | | | C20 H34 N O6 P | 415.461 | | 141702624 | 0 | 62 | 1 | 62 | 6 | 11 |
| B2O | 4-[6-(2-naphthalen-1-ylethoxy)-2,3,4,5-tetrahydro-1H-3-benzazepin-3-ium-3-yl]butanoic acid | | | C26 H30 N O3 | 404.521 | | 164607208 | 1 | 60 | 0 | 63 | 17 | 1 |
| U30 | Etrumadenant | Etrumadenant | | C23 H22 N8 O | 426.474 | | 135242184 | 0 | 54 | 0 | 57 | 23 | 3 |
| LJX | (2R,3R,4R)-2-[(8P)-6-amino-2-(hex-1-yn-1-yl)-8-(thiophen-2-yl)-9H-purin-9-yl]oxolane-3,4-diol | | | C19 H21 N5 O3 S | 399.467 | | 164885960 | 0 | 49 | 3 | 52 | 15 | 2 |
| T4U | Lorcaserin | Lorcaserin | | C11 H14 Cl N | 195.689 | | 11658860 | 0 | 27 | 1 | 28 | 6 | 6 |
| TKO | (4M)-6-bromo-4-(furan-2-yl)quinazolin-2-amine | | | C12 H8 Br N3 O | 290.115 | | 105526064 | 0 | 25 | 0 | 27 | 16 | 1 |
| U39 | 2-[(cyclopropanesulfonyl)amino]-N-(2-ethoxyphenyl)benzamide | | | C18 H20 N2 O4 S | 360.427 | | 71598556 | 0 | 45 | 0 | 47 | 12 | 2 |
| U2U | N-{2-[(1-aminoisoquinolin-6-yl)oxy]-4-methylphenyl}-2-methoxybenzene-1-sulfonamide | | | C23 H21 N3 O4 S | 435.496 | | 139030531 | 0 | 52 | 0 | 55 | 23 | 4 |
| U99 | methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(furan-3-yl)-9-(methoxymethoxy)-6a,10b-dimethyl-4,10-dioxododecahydro-2H-naphtho[2,1-c]pyran-7-carboxylate | | | C23 H30 O8 | 434.48 | | 44456192 | 0 | 61 | 7 | 64 | 5 | 4 |
| U9I | methyl (3R)-4-[(3,4-dichlorophenyl)acetyl]-3-[(pyrrolidin-1-yl)methyl]piperazine-1-carboxylate | | | C19 H25 Cl2 N3 O3 | 414.326 | | 6603856 | 0 | 52 | 1 | 54 | 6 | 4 |
| U8S | 3-[(2S)-2-hydroxy-2,3-dihydro-1H-imidazol-4-yl]-L-alanine | | | C6 H11 N3 O3 | 173.17 | | 168719763 | 0 | 23 | 2 | 23 | 0 | 1 |
| WEC | 11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine | | | C18 H20 N4 | 292.378 | | 16103 | 0 | 42 | 0 | 45 | 12 | 4 |
| WE9 | 8-chloro-11-(4-methyl-4-oxo-4lambda~5~-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine | | | C18 H19 Cl N4 O | 342.823 | | 135445691 | 0 | 43 | 0 | 46 | 12 | 2 |
| 7V7 | Fentanyl | Fentanyl CII | | C22 H28 N2 O | 336.471 | | 3345 | 0 | 53 | 0 | 55 | 12 | 2 |
| MOI | Morphine | Morfina | | C17 H19 N O3 | 285.338 | | 5288826 | 0 | 40 | 5 | 44 | 6 | 2 |
| WH2 | Oliceridine | Oliceridine | | C22 H30 N2 O2 S | 386.551 | | 66553195 | 0 | 57 | 1 | 60 | 11 | 2 |
| WH9 | 5,6-dichloro-1-{1-[(4-chlorophenyl)methyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one | | | C19 H18 Cl3 N3 O | 410.725 | | 130431397 | 0 | 44 | 0 | 47 | 12 | 2 |
| HXA | Doconexent | 4,7,10,13,16,19-docosahexaenoic acid | | C22 H32 O2 | 328.488 | | 445580 | 0 | 56 | 0 | 55 | 0 | 12 |
| PPI | Propanoic acid | - Propionic acid
- Sodium propionate
- Propanoic acid
| | C3 H6 O2 | 74.079 | | 1032 | 0 | 11 | 0 | 10 | 0 | 2 |
| DTH | D-THREONINE | | | C4 H9 N O3 | 119.119 | | 6995277 | 0 | 17 | 2 | 16 | 0 | 4 |
| XT9 | 6beta-amino-17-propyl-5alpha,9alpha,13alpha-4,5-epoxymorphinan-3,14-diol | | | C19 H26 N2 O3 | 330.421 | | 169491067 | 0 | 50 | 5 | 54 | 6 | 2 |
| SRW | 2-[{2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl}(methyl)amino]ethan-1-ol | | | C26 H31 F N4 O2 | 450.548 | | 118610427 | 0 | 64 | 0 | 68 | 17 | 10 |
| XNO | Xanomeline | (5M)-5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine | | C14 H23 N3 O S | 281.417 | | 60809 | 0 | 42 | 0 | 43 | 5 | 2 |
| YFW | 5-methoxy-N,N-dimethyltryptamine | 5-MeO-DMT | | C13 H18 N2 O | 218.295 | | 1832 | 0 | 34 | 0 | 35 | 10 | 2 |
| YGH | 4-fluoro-5-methoxy-3-[2-(pyrrolidin-1-yl)ethyl]-1H-indole | | | C15 H19 F N2 O | 262.323 | | 10015574 | 0 | 38 | 0 | 40 | 10 | 2 |
| YG7 | Vilazodone | - Vilazodone
- Vilazodone hydrochloride
- Vilazodonum
- Vilazodona
| | C26 H27 N5 O2 | 441.525 | | 6918314 | 0 | 60 | 0 | 64 | 20 | 2 |
| YLX | Buspirone | Buspirona | | C21 H31 N5 O2 | 385.503 | | 2477 | 0 | 59 | 0 | 62 | 6 | 6 |
| YI9 | 6-(octylamino)pyrimidine-2,4(3H,5H)-dione | | | C12 H21 N3 O2 | 239.314 | | 168719775 | 0 | 38 | 0 | 38 | 0 | 2 |
| LPC | [1-MYRISTOYL-GLYCEROL-3-YL]PHOSPHONYLCHOLINE | | | C22 H47 N O7 P | 468.585 | | 444675 | 1 | 78 | 2 | 77 | 0 | 2 |
| YN9 | 3-{4-[(4-fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]phenyl}propanoic acid | | | C23 H21 F O3 | 364.409 | | 57522038 | 0 | 48 | 0 | 50 | 18 | 8 |
| YVF | methyl (2R)-2-({(1M)-5-methyl-1-[3-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonyl}amino)-2-(thiophen-2-yl)propanoate | | | C20 H18 F3 N3 O3 S | 437.435 | | 170838490 | 0 | 48 | 1 | 50 | 16 | 5 |
| YX9 | (5S)-5-[(3R)-4,4-difluoro-3-hydroxy-4-phenylbutyl]-1-[6-(1H-tetrazol-5-yl)hexyl]pyrrolidin-2-one | | | C21 H29 F2 N5 O2 | 421.484 | | 25014543 | 0 | 59 | 2 | 61 | 11 | 2 |
| Z2C | 4-({2-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]butyl}cyclopentyl]ethyl}sulfanyl)butanoic acid | | | C23 H36 O6 S | 440.593 | | 169501697 | 0 | 66 | 5 | 67 | 6 | 2 |
| YZV | (2S,5R)-5-[(1E,3S)-4,4-difluoro-3-hydroxy-4-phenylbut-1-en-1-yl]-1-[6-(1H-tetrazol-5-yl)hexyl]pyrrolidin-2-ol | | | C21 H29 F2 N5 O2 | 421.484 | | | 0 | 59 | 3 | 61 | 11 | 2 |
| ZI5 | (5Z,8Z,11Z,13S,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-13-methylicosa-5,8,11,14-tetraenamide | | | C24 H41 N O2 | 375.588 | | 145964903 | 0 | 68 | 2 | 67 | 0 | 2 |
| JQR | ~{N}-[4-(furan-2-yl)-5-(oxan-4-ylcarbonyl)-1,3-thiazol-2-yl]-6-methyl-pyridine-3-carboxamide | | | C20 H19 N3 O4 S | 397.448 | | 23144148 | 0 | 47 | 0 | 50 | 16 | 1 |
| JQ9 | Istradefylline | istradefylline | | C20 H24 N4 O4 | 384.429 | | 5311037 | 0 | 52 | 0 | 54 | 11 | 3 |
| CW9 | 8-(4-bromanyl-2,6-dimethoxy-phenyl)-~{N},~{N}-bis(2-methoxyethyl)-2,7-dimethyl-pyrazolo[1,5-a][1,3,5]triazin-4-amine | | | C21 H28 Br N5 O4 | 494.382 | | 44517108 | 0 | 59 | 0 | 61 | 16 | 1 |
| 0JS | 8-(4-bromanyl-2,6-dimethoxy-phenyl)-~{N}-butyl-~{N}-(cyclopropylmethyl)-2,7-dimethyl-pyrazolo[1,5-a][1,3,5]triazin-4-amine | | | C23 H30 Br N5 O2 | 488.421 | | 168477797 | 0 | 61 | 0 | 64 | 16 | 1 |
| 0VI | 7-(4-bromanyl-2,6-dimethoxy-phenyl)-4,8-dimethyl-~{N},~{N}-bis[4,4,4-tris(fluoranyl)butyl]-1$l^{4},3,5,9-tetrazabicyclo[4.3.0]nona-1(6),2,4,8-tetraen-2-amine | | | C23 H27 Br F6 N5 O2 | 599.387 | | 168477862 | 0 | 64 | 1 | 66 | 12 | 1 |
| KNF | Olorinab | (2~{S},4~{S})-~{N}-[(2~{S})-3,3-dimethyl-1-oxidanyl-butan-2-yl]-9-(4-oxidanylpyrazin-2-yl)-8,9-diazatricyclo[4.3.0.0^{2,4}]nona-1(6),7-diene-7-carboxamide | | C18 H23 N5 O3 | 357.407 | | 60164925 | 0 | 49 | 3 | 52 | 11 | 2 |
| KO3 | Onternabez | - Onternabez
- [(1S,2S,5S)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol
| | C27 H42 O3 | 414.621 | | 11553430 | 0 | 72 | 3 | 74 | 6 | 2 |
| KO8 | 1-[[4-[5-fluoranyl-6-[(oxan-4-ylamino)methyl]pyridin-2-yl]phenyl]methyl]-3-(2-methylpropyl)imidazolidine-2,4-dione | | | C25 H31 F N4 O3 | 454.537 | | 46219896 | 0 | 64 | 0 | 67 | 12 | 2 |
| KHF | PCO-371 | 1-[3,5-dimethyl-4-[2-[[4-oxidanylidene-2-[4-(trifluoromethyloxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl]sulfonyl]ethyl]phenyl]-5,5-dimethyl-imidazolidine-2,4-dione | | C29 H32 F3 N5 O6 S | 635.654 | | 76283707 | 0 | 76 | 0 | 80 | 12 | 4 |
| NIO | Niacin | pyridine-β-carboxylic acid | | C6 H5 N O2 | 123.109 | | 117629482 | 0 | 14 | 0 | 14 | 6 | 17 |
| WPT | 3-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)propanoic acid | | | C22 H21 N O3 | 347.407 | | 11595431 | 0 | 47 | 0 | 49 | 18 | 2 |
| WYB | Lodoxamide | Lodoxamide | | C11 H6 Cl N3 O6 | 311.635 | | 44564 | 0 | 27 | 0 | 27 | 6 | 2 |
| 4AI | (3S)-N-[(2S)-5-carbamimidamido-1-(cyclohexylmethylamino)-1-oxidanylidene-pentan-2-yl]-2-(4-oxidanylidene-4-phenyl-butanoyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide | PS372424 | | C33 H44 N6 O4 | 588.74 | | 12000484 | 0 | 87 | 2 | 90 | 12 | 2 |
| 4IE | [4-(2-bromophenyl)phenyl]methyl-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]-dimethyl-azanium | VUF11222 | | C25 H31 Br N | 425.424 | | 71459295 | 1 | 58 | 2 | 61 | 12 | 2 |
| 43I | 3-azanyl-6-chloranyl-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethyl-piperazin-1-yl]pyrazine-2-carboxamide | | | C23 H31 Cl2 N7 O | 492.445 | | 11995774 | 0 | 64 | 1 | 67 | 12 | 1 |
| 140 | N-hexadecanoylglycine | N-Palmitoyl glycine | | C18 H35 N O3 | 313.475 | | 151008 | 0 | 57 | 0 | 56 | 0 | 2 |
| 9HO | 9(S)-HODE | - alpha-Dimorphecolic acid
- 9S-Hode
- 9(S)-HODE
- (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
| | C18 H32 O3 | 296.445 | | 5312830 | 0 | 53 | 1 | 52 | 0 | 2 |
| NFI | 3-methyl-5-[(4-oxidanylidene-4-phenyl-butanoyl)amino]-1-benzofuran-2-carboxylic acid | | | C20 H17 N O5 | 351.353 | | 168654812 | 0 | 43 | 0 | 45 | 16 | 2 |
| O6F | N-tert-butyl-N-ethyl-8-methoxy-9-propan-2-yloxy-1-thiophen-2-yl-5,6-dihydroimidazo[5,1-a]isoquinoline-3-carboxamide | | | C26 H33 N3 O3 S | 467.624 | | 67530240 | 0 | 66 | 0 | 69 | 16 | 2 |
| OJX | 5-methyl-4-oxidanyl-pyrazin-4-ium-2-carboxylic acid | | | C6 H7 N2 O3 | 155.131 | | 59806020 | 1 | 18 | 0 | 18 | 6 | 7 |
| OKL | 8-chloranyl-3-pentyl-7H-purine-2,6-dione | | | C10 H13 Cl N4 O2 | 256.689 | | 46215799 | 0 | 30 | 0 | 31 | 5 | 9 |
| ERY | Erythromycin | Abomacetin | | C37 H67 N O13 | 733.927 | | 12560 | 0 | 118 | 18 | 120 | 0 | 2 |
| 7NR | 9-Hydroxyoctadecanoic acid | 9-Hydroxystearic acid | | C18 H36 O3 | 300.477 | | 9601093 | 0 | 57 | 1 | 56 | 0 | 2 |
| EIC | Linoleic acid | all-cis-9,12-octadecadienoic acid | | C18 H32 O2 | 280.445 | | 5280450 | 0 | 52 | 0 | 51 | 0 | 2 |
| OLA | OLEIC ACID | | | C18 H34 O2 | 282.461 | | 445639 | 0 | 54 | 0 | 53 | 0 | 3 |
| EPA | Icosapent | Eicosapentaenoic acid | | C20 H30 O2 | 302.451 | | 446284 | 0 | 52 | 0 | 51 | 0 | 2 |
| P8A | 5-butyl-1~{H}-pyrazole-3-carboxylic acid | | | C8 H12 N2 O2 | 168.193 | | 6485181 | 0 | 24 | 0 | 24 | 5 | 2 |
| P9X | (5~{S})-5-methyl-4-oxidanylidene-5-phenyl-furan-2-carboxylic acid | Acifran | | C12 H10 O4 | 218.205 | | 76969700 | 0 | 26 | 1 | 27 | 6 | 5 |
| Q2B | 3-[(1S)-1-(furan-2-yl)-2-nitro-ethyl]-2-phenyl-1H-indole | | | C20 H16 N2 O3 | 332.353 | | 703205 | 0 | 41 | 1 | 44 | 21 | 2 |
| Q2L | 3-[(1R)-1-(2-methoxyphenyl)-2-nitro-ethyl]-2-phenyl-1H-indole | | | C23 H20 N2 O3 | 372.417 | | 171393541 | 0 | 48 | 1 | 51 | 22 | 2 |
| 87Q | Carboprost | (e,z)-(1r,2r,3r,5s)-7-(3,5-dihydroxy-2-((3s)-(3-hydroxy-3-methyl-1-octenyl))cyclopentyl)-5-heptenoic acid | | C21 H36 O5 | 368.508 | | 5281075 | 0 | 62 | 5 | 62 | 0 | 2 |
| 7WT | Latanoprost acid | 7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoic acid | | C23 H34 O5 | 390.513 | | 6441636 | 0 | 62 | 5 | 63 | 6 | 6 |
| R5F | Rotigotine | (6~{S})-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol | | C19 H25 N O S | 315.473 | | 59227 | 0 | 47 | 1 | 49 | 11 | 10 |
| 8IA | ~{N},~{N}-dimethylcyclohexanamine | | | C8 H17 N | 127.227 | | 7415 | 0 | 26 | 0 | 26 | 0 | 4 |
| UGU | Dinoprost | Dinoprost; Prostaglandin F2a; PGF2alpha | | C20 H34 O5 | 354.481 | | 5280363 | 0 | 59 | 5 | 59 | 0 | 4 |
| S2F | (~{Z})-7-[(1~{R},2~{R},3~{R},5~{S})-2-[(~{E})-3,3-bis(fluoranyl)-4-phenoxy-but-1-enyl]-3,5-bis(oxidanyl)cyclopentyl]hept-5-enoic acid | Tafluprost acid | | C22 H28 F2 O5 | 410.452 | | 9978917 | 0 | 57 | 4 | 58 | 6 | 2 |
| SPD | Spermidine | 4-azaoctane-1,8-diamine | | C7 H19 N3 | 145.246 | | 1102 | 0 | 29 | 0 | 28 | 0 | 3 |
| PEA | Phenethylamine | benzeneethanamine | | C8 H12 N | 122.188 | | 448751 | 1 | 21 | 0 | 21 | 6 | 9 |
| S6R | 1-[4-(3-chlorophenyl)phenyl]carbonyl-4-[2-(4-phenylmethoxyphenyl)ethanoylamino]piperidine-4-carboxylic acid | | | C34 H31 Cl N2 O5 | 583.073 | | 169422747 | 0 | 73 | 0 | 77 | 24 | 1 |
| TJR | [(2~{R})-2-oxidanyl-3-phosphonooxy-propyl] octadecanoate | | | C21 H43 O7 P | 438.536 | | 9547179 | 0 | 72 | 1 | 71 | 0 | 2 |
| UBL | [(2R)-2-oxidanyl-3-phosphonooxy-propyl] (Z)-octadec-9-enoate | | | C21 H41 O7 P | 436.52 | | 5311263 | 0 | 70 | 1 | 69 | 0 | 4 |
| HXD | (3R)-3-HYDROXYDODECANOIC ACID | 3-OH-DODECANOATE | | C12 H24 O3 | 216.317 | | 5312804 | 0 | 39 | 1 | 38 | 0 | 2 |
| SWO | 6-nonylpyridine-2,4-diol | | | C14 H23 N O2 | 237.338 | | 127045422 | 0 | 40 | 0 | 40 | 6 | 2 |
| 9T4 | (4R)-N-[2,5-bis(chloranyl)phenyl]-4-(furan-2-yl)-2-methyl-5-oxidanylidene-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide | | | C21 H18 Cl2 N2 O3 | 417.285 | | 124893090 | 0 | 46 | 1 | 49 | 11 | 2 |
| LEA | N-Valeric Acid | VALERIC ACID | | C5 H10 O2 | 102.132 | | 7991 | 0 | 17 | 0 | 16 | 0 | 2 |
| BUA | Butyric Acid | Sodium butyrate | | C4 H8 O2 | 88.105 | | 264 | 0 | 14 | 0 | 13 | 0 | 6 |
| 9UJ | (2R,4R)-2-(2-chlorophenyl)-3-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]carbonyl-1,3-thiazolidine-4-carboxylic acid | TUG-1375 | | C22 H19 Cl N2 O4 S | 442.915 | | 138319694 | 0 | 49 | 2 | 52 | 17 | 12 |
| ACT | Acetate | Acetate anion | | C2 H3 O2 | 59.044 | | 175 | -1 | 7 | 0 | 6 | 0 | 2 |
| IX8 | 7-methyl-N-[(2R)-1-phenoxypropan-2-yl]-3-(4-propan-2-ylphenyl)pyrazolo[1,5-a]pyrimidine-6-carboxamide | | | C26 H28 N4 O2 | 428.526 | | 25101223 | 0 | 60 | 1 | 63 | 22 | 8 |
| 3HR | (3R)-3-hydroxybutanoic acid | | | C4 H8 O3 | 104.105 | | 92135 | 0 | 15 | 1 | 14 | 0 | 2 |
| BQI | 5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)-1,3-thiazol-2-amine | ADX88178 | | C12 H12 N6 S | 272.329 | | 46836872 | 0 | 31 | 0 | 33 | 16 | 2 |
| BK0 | N-(3-chlorophenyl)pyridine-2-carboxamide | | | C12 H9 Cl N2 O | 232.666 | | 836002 | 0 | 25 | 0 | 26 | 12 | 2 |
| 3HO | (3S)-3-hydroxyoctanoic acid | | | C8 H16 O3 | 160.211 | | 11367166 | 0 | 27 | 1 | 26 | 0 | 2 |
| CW3 | 3-nitro-4-(propylamino)benzoic acid | 68740-31-8 | | C10 H12 N2 O4 | 224.213 | | 11715556 | 0 | 28 | 0 | 28 | 6 | 2 |
| UR9 | Monomethyl fumarate | (E)-4-methoxy-4-oxidanylidene-but-2-enoic acid | | C5 H6 O4 | 130.099 | | 5369209 | 0 | 15 | 0 | 14 | 0 | 2 |
| AW9 | (2Z)-4-methoxy-4-oxobut-2-enoic acid | | | C5 H6 O4 | 130.099 | | 5354456 | 0 | 15 | 0 | 14 | 0 | 2 |
| DSN | D-Serine | D-Serine | | C3 H7 N O3 | 105.093 | | 6857549 | 0 | 14 | 1 | 13 | 0 | 2 |
| DZQ | Olodaterol | 868049-49-4 | | C21 H26 N2 O5 | 386.442 | | 11504295 | 0 | 54 | 1 | 56 | 12 | 1 |
| UJF | 4-[4-(2-azanylethyl)-2-iodanyl-phenoxy]phenol | | | C14 H14 I N O2 | 355.171 | | 9950514 | 0 | 32 | 0 | 33 | 12 | 4 |
| UJL | SEP-363856 | Ulotaront; SEP-363856; SEP-856 | | C9 H13 N O S | 183.271 | | 89532783 | 0 | 25 | 1 | 26 | 5 | 12 |
| UJU | Ralmitaront | Ralmitaront | | C17 H22 N4 O2 | 314.382 | | 130429734 | 0 | 45 | 1 | 47 | 11 | 2 |
| VRK | (1~{S},3~{R})-3-(1-adamantyl)-1-(aminomethyl)-3,4-dihydro-1~{H}-isochromene-5,6-diol | | | C20 H27 N O3 | 329.433 | | | 0 | 51 | 2 | 55 | 6 | 2 |
| UQL | 2-(5-chloranyl-2-methyl-1~{H}-indol-3-yl)-N,N-dimethyl-ethanamine | ST1936 | | C13 H17 Cl N2 | 236.74 | | 9921064 | 0 | 33 | 0 | 34 | 10 | 2 |
| ALF | Tetrafluoroaluminate Ion | - Tetrafluoroaluminate Ion
- Tetrafluoroaluminate anion
- tetrafluoroaluminate(1−)
| | Al F4 | 102.975 | | 5311325 | -1 | 5 | 0 | 4 | 0 | 4 |
| STU | Staurosporine | Staurosporine | | C28 H26 N4 O3 | 466.531 | | 44259 | 0 | 61 | 4 | 68 | 24 | 4 |
| U9S | (2R,3S)-oxirane-2,3-dicarboxylic acid | cis-2,3-epoxysuccinic acid | | C4 H4 O5 | 132.072 | | 2734802 | 0 | 13 | 2 | 13 | 0 | 4 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | dioctanoyl l-alpha-phosphatidyl-d-myo-inositol 4,5-diphosphate | | C25 H49 O19 P3 | 746.566 | | 9543520 | 0 | 96 | 7 | 96 | 0 | 2 |
| 1WE | Dextroamphetamine | (S)-1-phenyl-2-aminopropane | | C9 H13 N | 135.206 | | 5826 | 0 | 23 | 1 | 23 | 6 | 2 |
| UYI | Anamorelin | - Anamorelin Hydrochloride
- Anamorelin
| | C31 H42 N6 O3 | 546.704 | | 9828911 | 0 | 82 | 2 | 85 | 16 | 2 |
| EZX | 1-(4-fluorophenyl)-4-[(7R)-2,5,11-triazatetracyclo[7.6.1.0^2,7.0^12,16]hexadeca-1(15),9,12(16),13-tetraen-5-yl]butan-1-one | | | C23 H24 F N3 O | 377.455 | | 170838539 | 0 | 52 | 1 | 56 | 16 | 3 |
| VBF | 3-[2-azanyl-6-[2-oxidanylidene-1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]pyridin-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile | | | C26 H24 N6 O2 | 452.508 | | 168451710 | 0 | 58 | 0 | 61 | 18 | 1 |
| V6X | 4-[3-methyl-4-(6-methylimidazo[1,2-a]pyrazin-5-yl)phenoxy]furo[3,2-c]pyridine | PF-6142 | | C21 H16 N4 O2 | 356.377 | | 75201901 | 0 | 43 | 0 | 47 | 26 | 1 |
| VBU | Clozapine | 3-chloranyl-6-(4-methylpiperazin-1-yl)-11~{H}-benzo[b][1,4]benzodiazepine | | C18 H19 Cl N4 | 326.823 | | 135398737 | 0 | 42 | 0 | 45 | 12 | 2 |
| VCF | 2-chloranyl-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine | VUF-6884 | | C18 H18 Cl N3 O | 327.808 | | 11846300 | 0 | 41 | 0 | 44 | 12 | 2 |
| VCL | 3-(1~{H}-imidazol-4-yl)propyl ~{N}'-[(4-chlorophenyl)methyl]carbamimidothioate | Clobenpropit | | C14 H17 Cl N4 S | 308.83 | | 2790 | 0 | 37 | 0 | 38 | 11 | 2 |
| FI6 | N-[(1R)-1-[3-(4-ethoxyphenyl)-4-oxidanylidene-pyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyloxy)phenyl]ethanamide | (+/-)-AMG 487 | | C32 H28 F3 N5 O4 | 603.591 | | 24957182 | 0 | 72 | 1 | 76 | 24 | 1 |
| VF0 | (2R)-2-azanyl-3-[oxidanyl-[(2R)-2-oxidanyl-3-tetradec-9-enoyloxy-propoxy]phosphoryl]oxy-propanoic acid | | | C20 H38 N O9 P | 467.491 | | 168719765 | 0 | 69 | 2 | 68 | 0 | 2 |
| JW0 | (4~{R})-4-[(3~{R},5~{R},8~{R},9~{S},10~{S},12~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-12-oxidanyl-3-phosphonooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoic acid | | | C24 H41 O7 P | 472.552 | | 172408416 | 0 | 73 | 10 | 76 | 0 | 3 |
| J3O | Fenofibrate | Fenofibrato | | C20 H21 Cl O4 | 360.831 | | 3339 | 0 | 46 | 0 | 47 | 12 | 2 |
| VV9 | (2~{S})-2-(3-bromanyl-4-methoxy-phenyl)-3-(4-chlorophenyl)sulfonyl-1,3-thiazolidine | BMS-986122 | | C16 H15 Br Cl N O3 S2 | 448.782 | | 1271268 | 0 | 39 | 1 | 41 | 12 | 4 |
| OS9 | 8-[[3-(2-methoxyphenoxy)phenyl]methyl]-1-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-4-one | LMD-009 | | C29 H33 N3 O3 | 471.591 | | 91032188 | 0 | 68 | 0 | 72 | 18 | 2 |
| OXF | 2-[2-[4-[(3-phenoxyphenyl)methyl]piperazin-1-yl]ethoxy]ethanol | ZK-756326 | | C21 H28 N2 O3 | 356.459 | | 11688990 | 0 | 54 | 0 | 56 | 12 | 2 |
| LPS | Lysophosphotidylserine | LYSOPHOSPHOTIDYLSERINE | | C21 H44 N O9 P | 485.549 | | 17754066 | 0 | 76 | 4 | 75 | 0 | 2 |
| ZL9 | 6-[3-[2-(2-methoxyphenoxy)ethylamino]propoxy]-4~{H}-1,4-benzoxazin-3-one | | | C20 H24 N2 O5 | 372.415 | | 171392444 | 0 | 51 | 0 | 53 | 12 | 2 |
| ZKV | Befiradol | - (3-chloro-4-fluorophenyl)(4-fluoro-4-((((5-methylpyridin-2-yl)methyl)amino)methyl)piperidin-1-yl)methanone
- Befiradol
- (2E)-2-butenedioate
- 4-piperidinemethanamine
| | C20 H22 Cl F2 N3 O | 393.858 | | 9865384 | 0 | 49 | 0 | 51 | 12 | 4 |
| FLF | Flufenamic acid | FLUFENAMIC ACID | | C14 H10 F3 N O2 | 281.23 | | 3371 | 0 | 30 | 0 | 31 | 12 | 6 |
| S12 | O-[(S)-hydroxy{[(2S)-2-hydroxy-3-(octadec-9-enoyloxy)propyl]oxy}phosphoryl]-L-serine | 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine | | C24 H46 N O9 P | 523.597 | | 137349977 | 0 | 81 | 2 | 80 | 0 | 2 |
| SPM | Spermine | 4,9-diazadodecane-1,12-diamine | | C10 H26 N4 | 202.34 | | 1103 | 0 | 40 | 0 | 39 | 0 | 5 |
| XY8 | 3-{4-[(2,4-difluorophenyl)methyl]piperazin-1-yl}-7-methyl-N-(propan-2-yl)pyrido[3,4-b]pyrazin-2-amine | | | C22 H26 F2 N6 | 412.479 | | 118310209 | 0 | 56 | 0 | 59 | 17 | 1 |
| X7T | CVN-424 | - ETHANONE, 1-(2-(4-(2,4-DIFLUOROPHENOXY)-1-PIPERIDINYL)-7,8-DIHYDRO-3-(((3R)-TETRAHYDRO-3-FURANYL)AMINO)PYRIDO(3,4-B)PYRAZIN-6(5H)-YL)-
- CVN-424
| | C24 H29 F2 N5 O3 | 473.516 | | 137359492 | 0 | 63 | 1 | 67 | 12 | 1 |
| YKU | 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | | | C23 H16 N4 O | 364.399 | | 11245456 | 0 | 44 | 0 | 47 | 23 | 2 |
| ZOB | 6-{[(3,5-difluoropyridin-4-yl)methyl]amino}-N-(4-ethoxy-6-methylpyrimidin-2-yl)-2-methoxy-N-(2-methoxyethyl)pyridine-3-sulfonamide | | | C22 H26 F2 N6 O5 S | 524.541 | | 168510218 | 0 | 62 | 0 | 64 | 18 | 1 |
| LSN | Losartan | Losartan | | C22 H23 Cl N6 O | 422.911 | | 3961 | 0 | 53 | 0 | 56 | 22 | 2 |
| CGZ | N-[(5S)-5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide | | | C14 H19 N3 O3 S | 309.384 | | 10804826 | 0 | 40 | 1 | 42 | 6 | 2 |
| W92 | (1R,4R,5S,6R)-4-azanyl-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid | | | C7 H9 N O5 | 187.15 | | 99643104 | 0 | 22 | 4 | 23 | 0 | 2 |
| JIX | (1S,4R,5R,6S)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid | | | C7 H9 N O5 | 187.15 | | 92460481 | 0 | 22 | 4 | 23 | 0 | 1 |
| VH6 | Plerixafor | 1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane); AMD3100 | | C28 H54 N8 | 502.782 | | 65015 | 0 | 90 | 0 | 92 | 6 | 3 |
| WRU | Mianserin | | | C18 H20 N2 | 264.365 | | 154315 | 0 | 40 | 1 | 43 | 12 | 2 |
| WOQ | Setiptiline | [4a(13b)M,13aM]-2-methyl-2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine; Tecipul; delta(13b,4a),4a-Carba-mianserin; MO-8282; ORG-8282 | | C19 H19 N | 261.361 | | 5205 | 0 | 39 | 0 | 42 | 12 | 2 |
| WV8 | (2R,4S)-4-[(2S)-2-phenylbutyl]-1,3-oxazolidin-2-amine | | | C13 H18 N2 O | 218.295 | | 24963286 | 0 | 34 | 2 | 35 | 6 | 2 |
| XOT | (4aR,5aR)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxylic acid | MK 1903 | | C8 H8 N2 O2 | 164.161 | | 49763030 | 0 | 20 | 2 | 22 | 5 | 4 |
| XI9 | (3M,4aR,5aR)-3-(1H-tetrazol-5-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole | | | C8 H8 N6 | 188.189 | | 58708479 | 0 | 22 | 2 | 25 | 10 | 3 |
| XUQ | Levomenthol | L-menthol | | C10 H20 O | 156.265 | | 16666 | 0 | 31 | 3 | 31 | 0 | 2 |
| 0WU | (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one | S-carvone | | C10 H14 O | 150.218 | | 16724 | 0 | 25 | 1 | 25 | 0 | 2 |
| XVT | (2R)-2-methyl-1,3-thiazolidine | | | C4 H9 N S | 103.186 | | 6999028 | 0 | 15 | 1 | 15 | 0 | 2 |
| YEQ | 4-{(3R)-1-[(1R)-1-(pyrimidin-2-yl)ethyl]piperidin-3-yl}phenol | | | C17 H21 N3 O | 283.368 | | | 0 | 42 | 2 | 44 | 12 | 2 |
| B40 | Metamfetamine | (αS)-N,α-dimethylbenzeneethanamine | | C10 H15 N | 149.233 | | 10836 | 0 | 26 | 1 | 26 | 6 | 4 |
| T5U | (4S)-4-[(2S)-2-phenylbutyl]-1,3-oxazolidin-2-imine | RO5256390 | | C13 H18 N2 O | 218.295 | | 24963286 | 0 | 34 | 2 | 35 | 6 | 2 |
| U7D | 1-(4-methylpyridin-2-yl)-3-[3-(trifluoromethyl)phenyl]thiourea | CHEMBL2134995 | | C14 H12 F3 N3 S | 311.325 | | 848971 | 0 | 33 | 0 | 34 | 12 | 3 |
| VMT | 2-(4-bromophenyl)ethanamine | 4-Bromophenethylamine | | C8 H10 Br N | 200.076 | | 533915 | 0 | 20 | 0 | 20 | 6 | 6 |
| TMA | Tetramethylammonium | - Tetramethylammonium
- Trimethylaminomethane
| | C4 H12 N | 74.145 | | 6380 | 1 | 17 | 0 | 16 | 0 | 2 |
| VMK | 2-[4-(3-fluorophenyl)phenyl]ethanamine | | | C14 H14 F N | 215.266 | | 39243566 | 0 | 30 | 0 | 31 | 12 | 2 |
| HAI | Cyclohexylammonium Ion | Cyclohexylammonium Ion | | C6 H14 N | 100.182 | | 70192317 | 1 | 21 | 0 | 21 | 0 | 3 |
| WCH | (2S,3S,4R,5R)-5-(6-amino-2-((E)-phenyldiazenyl)-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide | | | C18 H20 N8 O4 | 412.403 | | | 0 | 50 | 4 | 53 | 16 | 1 |
| E7P | (2S)-2-amino-4-phosphonobutanoic acid | | | C4 H10 N O5 P | 183.1 | | 57689795 | 0 | 21 | 1 | 20 | 0 | 1 |
| W9R | (1R,2S)-2-[[3,5-bis(chloranyl)phenyl]carbamoyl]cyclohexane-1-carboxylic acid | | | C14 H15 Cl2 N O3 | 316.18 | | 888023 | 0 | 35 | 2 | 36 | 6 | 2 |
| WAG | (1S,2R)-2-[(2S)-2-azanyl-1-oxidanyl-1-oxidanylidene-3-(9H-xanthen-9-yl)propan-2-yl]cyclopropane-1-carboxylic acid | | | C20 H19 N O5 | 353.369 | | 6604829 | 0 | 45 | 4 | 48 | 12 | 1 |
| WA6 | (2S)-2-azanyl-2-cyclopropyl-2-(4-phosphonophenyl)ethanoic acid | | | C11 H14 N O5 P | 271.206 | | 11459929 | 0 | 32 | 1 | 33 | 6 | 1 |
| ADP | Adenosine disphosphate | - ADP
- Adenosine disphosphate
| | C10 H15 N5 O10 P2 | 427.201 | | 6022 | 0 | 42 | 5 | 44 | 10 | 2 |
| XQT | VU0424465 | 5-[2-(3-fluorophenyl)ethynyl]-~{N}-[(2~{R})-3-methyl-3-oxidanyl-butan-2-yl]pyridine-2-carboxamide | | C19 H19 F N2 O2 | 326.365 | | 53384864 | 0 | 43 | 1 | 44 | 12 | 3 |
| XRQ | VU29 | N-(1,3-Diphenyl-1H-pyrazolo-5-yl)-4-nitrobenzamide; ~{N}-(2,5-diphenylpyrazol-3-yl)-4-nitro-benzamide | | C22 H16 N4 O3 | 384.387 | | 11610682 | 0 | 45 | 0 | 48 | 23 | 1 |
| Q8L | Piclidenoson | (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboxamide (non-preferred name) | | C18 H19 I N6 O4 | 510.286 | | 123683 | 0 | 48 | 4 | 51 | 16 | 4 |
| XS0 | Namodenoson | (2~{S},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-[(3-iodanylphenyl)methylamino]purin-9-yl]-~{N}-methyl-3,4-bis(oxidanyl)oxolane-2-carboxamide; CF102; Cl-IB-MECA | | C18 H18 Cl I N6 O4 | 544.731 | | 3035850 | 0 | 48 | 4 | 51 | 16 | 4 |
| 5YM | Oleic monoethanolamide | N-(2-Hydroxyethyl)oleamide | | C20 H39 N O2 | 325.529 | | 5283454 | 0 | 62 | 0 | 61 | 0 | 2 |
| XWD | 4-[3-(4-fluoranyl-2~{H}-indazol-7-yl)-1,2,4-oxadiazol-5-yl]-1-(4-fluorophenyl)azepan-2-one | | | n/a | 409.389 | | 172458163 | 0 | 47 | 1 | 51 | 21 | 2 |
| XB7 | Astemizole | 1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole | | C28 H31 F N4 O | 458.57 | | 2247 | 0 | 65 | 0 | 69 | 22 | 1 |
| Y5E | Mepyramine | Mepyramine | | C17 H23 N3 O | 285.384 | | 4992 | 0 | 44 | 0 | 45 | 12 | 1 |
| Y5R | Desloratadine | 13-chloranyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene | | C19 H19 Cl N2 | 310.821 | | 124087 | 0 | 41 | 0 | 44 | 12 | 1 |
| Y9Q | 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-yl-amino]butoxy]ethanoic acid | | | C25 H29 N3 O3 | 419.516 | | 9931891 | 0 | 60 | 0 | 62 | 18 | 2 |
| Y9J | Treprostinil | Treprostinilum | | C23 H34 O5 | 390.513 | | 6918140 | 0 | 62 | 5 | 64 | 6 | 2 |
| DHT | Stanolone | 17beta-Hydroxy-5alpha-androstan-3-one | | C19 H30 O2 | 290.44 | | 10635 | 0 | 51 | 7 | 54 | 0 | 6 |
| YNH | methyl 3-[2-(2,4-dimethylphenoxy)ethanoylamino]-4-(4-ethylpiperazin-1-yl)benzoate | | | C24 H31 N3 O4 | 425.521 | | 7346086 | 0 | 62 | 0 | 64 | 12 | 2 |
| KW0 | (2~{S})-2-azanyl-3-[[(2~{R})-1-ethoxy-3-[(~{Z})-octadec-9-enoyl]oxy-propan-2-yl]oxy-oxidanyl-phosphoryl]oxy-propanoic acid | | | C26 H50 N O9 P | 551.65 | | 118584207 | 0 | 87 | 2 | 86 | 0 | 3 |
| KW3 | (2~{S})-2-azanyl-3-[[(2~{R})-1-ethoxy-3-[3-[2-[(3-phenoxyphenyl)methoxy]phenyl]propanoyloxy]propan-2-yl]oxy-oxidanyl-phosphoryl]oxy-propanoic acid | | | C30 H36 N O11 P | 617.581 | | 162656636 | 0 | 79 | 2 | 81 | 18 | 3 |
| UYA | (4R)-4-hydroxy-D-proline | | | C5 H9 N O3 | 131.13 | | 440014 | 0 | 18 | 2 | 18 | 0 | 2 |
| XZA | diazanecarboxylic acid | | | C H4 N2 O2 | 76.055 | | 129728243 | 0 | 9 | 0 | 8 | 0 | 6 |
| NMM | Tilarginine | L-Ng-monomethyl Arginine | | C7 H16 N4 O2 | 188.228 | | 46906075 | 0 | 29 | 1 | 28 | 0 | 6 |
| HZP | (4S)-4-hydroxy-L-proline | | | C5 H9 N O3 | 131.13 | | 6971054 | 0 | 18 | 2 | 18 | 0 | 2 |
| PUC | (5Z)-7-{(1R,4S,5S,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2-oxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | | C21 H34 O4 | 350.492 | | 5311493 | 0 | 59 | 5 | 60 | 0 | 4 |
| GOQ | 8-methoxy-6-nitro-naphtho[1,2-e][1,3]benzodioxole-5-carboxylic acid | | | C17 H11 N O7 | 341.272 | | 2236 | 0 | 36 | 0 | 39 | 16 | 8 |
| PFS | Platelet Activating Factor | Platelet-activating factor | | C26 H54 N O7 P | 523.683 | | 108156 | 0 | 89 | 1 | 88 | 0 | 2 |
| MED | D-Methionine | D-Methionine | | C5 H11 N O2 S | 149.211 | | 84815 | 0 | 20 | 1 | 19 | 0 | 2 |
| NAL | Beta-(2-Naphthyl)-Alanine | Beta-(2-Naphthyl)-Alanine | | C13 H13 N O2 | 215.248 | | 6927613 | 0 | 29 | 1 | 30 | 11 | 2 |
| 16C | N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)PALMITAMIDE | C16-CERAMIDE; N-PALMITOYL-D-ERYTHRO-SPHINGOSINE; (2S,3R,4E)-2-PALMITOYLAMINOOCTADEC-4-ENE-1,3-DIOL; (2S,3R,4E)-2-PALMITOYLAMINO-1,3-OCTADEC-4-ENEDIOL | | C34 H67 N O3 | 537.901 | | 5283564 | 0 | 105 | 2 | 104 | 0 | 4 |
| 6MD | N-methyladenosine | | | C11 H15 N5 O4 | 281.268 | | 102175 | 0 | 35 | 4 | 37 | 10 | 2 |
| ZIR | Riboprine | | | C15 H21 N5 O4 | 335.358 | | 24405 | 0 | 45 | 4 | 47 | 10 | 2 |
| MW9 | (21R,24R,27S)-24,27,28-trihydroxy-18,24-dioxo-19,23,25-trioxa-24lambda~5~-phosphaoctacosan-21-yl (9Z)-octadec-9-enoate | 1-stearoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) | | C42 H81 O10 P | 777.06 | | 24779551 | 0 | 134 | 2 | 133 | 0 | 3 |
| MAE | Maleic acid | cis-Butenedioic acid | | C4 H4 O4 | 116.072 | | 444266 | 0 | 12 | 0 | 11 | 0 | 2 |
| 2ML | alpha-Methylleucine | - alpha-Methylleucine
- (S)-2-Methylleucine
- 2-Methyl-L-leucine
| | C7 H15 N O2 | 145.199 | | 6951130 | 0 | 25 | 1 | 24 | 0 | 8 |
| AKG | Oxogluric acid | 2-oxoglutaric acid | | C5 H6 O5 | 146.098 | | 51 | 0 | 16 | 0 | 15 | 0 | 2 |
| 004 | (2S)-amino(phenyl)ethanoic acid | L-Phenylglycine | | C8 H9 N O2 | 151.163 | | 6931074 | 0 | 20 | 1 | 20 | 6 | 8 |
| PHA | PHENYLALANINAL | | | C9 H11 N O | 149.19 | | 446207 | 0 | 22 | 1 | 22 | 6 | 4 |
| HYP | Hydroxyproline | HYDROXYPROLINE | | C5 H9 N O3 | 131.13 | | 5810 | 0 | 18 | 2 | 18 | 0 | 4 |
| ACY | Acetic acid | Acetic acid, glacial | | C2 H4 O2 | 60.052 | | 176 | 0 | 8 | 0 | 7 | 0 | 2 |
| PG2 | Prostaglandin D2 | (5E,13E)-9,15-DIHYDROXY-11-OXOPROSTA-5,13-DIEN-1-OIC ACID | | C20 H32 O5 | 352.465 | | 448457 | 0 | 57 | 4 | 57 | 0 | 4 |
| XCP | (1S,2S)-2-aminocyclopentanecarboxylic acid | | | C6 H11 N O2 | 129.157 | | 10997062 | 0 | 20 | 2 | 20 | 0 | 2 |
| DVA | D-VALINE | | | C5 H11 N O2 | 117.146 | | 71563 | 0 | 19 | 1 | 18 | 0 | 2 |
| ALO | ALLO-THREONINE | | | C4 H9 N O3 | 119.119 | | 6995276 | 0 | 17 | 2 | 16 | 0 | 2 |
| LTD | Leukotriene D4 | - Leukotriene D4
- S-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-L-cysteinylglycine
- LTD4
- (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine
- 5S-hydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11E,14Z-eicosatetraenoic acid
| | C25 H40 N2 O6 S | 496.66 | | 5280878 | 0 | 74 | 3 | 73 | 0 | 2 |
| NAI | NADH | Nicotinamide-adenine dinucleotide, reduced | | C21 H29 N7 O14 P2 | 665.441 | | 439153 | 0 | 73 | 10 | 77 | 10 | 2 |
| UGA | UDP-alpha-D-glucuronic acid | uridine diphosphate glucuronic acid | | C15 H22 N2 O18 P2 | 580.285 | | 17473 | 0 | 59 | 11 | 61 | 6 | 2 |
| 18C | N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)STEARAMIDE | C18-CERAMIDE; N-STEAROYL-D-ERYTHRO-SPHINGOSINE; (2S,3R,4E)-2-STEAROYLAMINOOCTADEC-4-ENE-1,3-DIOL; (2S,3R,4E)-2-STEAROYLAMINO-1,3-OCTADEC-4-ENEDIOL | | C36 H71 N O3 | 565.954 | | 5283565 | 0 | 111 | 2 | 110 | 0 | 2 |
| ZIT | Azithromycin | Azithromycine | | C38 H72 N2 O12 | 748.984 | | 447043 | 0 | 124 | 18 | 126 | 0 | 2 |
| UTP | Uridine 5'-triphosphate | - Uridine 5'-triphosphate
- Uridine triphosphate
| | C9 H15 N2 O15 P3 | 484.141 | | 6133 | 0 | 44 | 6 | 45 | 6 | 2 |
| ATP | ATP | Adenosine triphosphate disodium trihydrate | | C10 H16 N5 O13 P3 | 507.181 | | 5957 | 0 | 47 | 6 | 49 | 10 | 4 |
| SA0 | Salicin | D-salicin | | C13 H18 O7 | 286.278 | | 439503 | 0 | 38 | 5 | 39 | 6 | 8 |
| A1L | [2-[[(2S)-1-[bis(phenylmethyl)amino]-5-[[N-(methylcarbamoyl)carbamimidoyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-diazonio-azanide | | | C24 H31 N9 O3 | 493.561 | | 44129754 | 0 | 67 | 1 | 68 | 12 | 22 |
| A1A | 6-AMINO HEXANOIC ACID | | | C33 H40 N4 O6 | 588.694 | | 5327090 | 0 | 83 | 4 | 86 | 18 | 17 |
| A1D | | | | | | | | | | | | | 27 |
| TY5 | O-benzyl-L-tyrosine | | | C16 H17 N O3 | 271.311 | | 725701 | 0 | 37 | 1 | 38 | 12 | 6 |
| NIT | 4-NITROANILINE | PARANITROANILINE | | C6 H6 N2 O2 | 138.124 | | 7475 | 0 | 16 | 0 | 16 | 6 | 2 |
| FC0 | N-CARBOXY-L-PHENYLALANINE | | | C10 H11 N O4 | 209.199 | | 20637693 | 0 | 26 | 1 | 26 | 6 | 2 |
| IMN | Indomethacin | 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid | | C19 H16 Cl N O4 | 357.788 | | 3715 | 0 | 41 | 0 | 43 | 16 | 2 |
| A1B | 1-deoxy-alpha-L-xylulofuranose-1,2-borate | | | C5 H10 B O6 | 176.94 | | 118797262 | -1 | 22 | 3 | 23 | 0 | 10 |
| HOH | Water | Sterile water | | H2 O | 18.015 | | 962 | 0 | 3 | 0 | 2 | 0 | 1 |
| A1H | Molidustat | - Molidustat
- Molidustat sodium
| | C13 H14 N8 O2 | 314.303 | | 59603622 | 0 | 37 | 0 | 40 | 11 | 5 |
| A1I | N-(cyclopent-3-ene-1-carbonyl)-L-histidine | | | C12 H15 N3 O3 | 249.266 | | 64766902 | 0 | 33 | 1 | 34 | 5 | 5 |
| A1E | (R)-tacrine(10)-hupyridone | (R)-N-9 -(1 ,2 ,3 ,4 -TETRAHYDROACRIDINYL)-N'-5 -[5 ,6 ,7 ,8 -TETRAHYDRO-2'(1'H)-QUINOLINONYL]-1,10-DIAMINODECANE; (R)-TACRINE(10)-HUPYRIDONE | | C32 H44 N4 O | 500.718 | | 5287575 | 0 | 81 | 1 | 85 | 17 | 5 |
| _L_ | | | | | | | | | | | | | 131 |
| A1C | 1-(3-chloro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide | | | C20 H23 Cl N2 O3 S | 406.926 | | 131800983 | 0 | 50 | 0 | 52 | 12 | 1 |
| _W_ | | | | | | | | | | | | | 17 |
| RRY | 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranose | | | C6 H10 Cl2 O4 | 217.047 | | 67253069 | 0 | 22 | 4 | 22 | 0 | 1 |
| RRJ | 4-chloro-4-deoxy-alpha-D-galactopyranose | | | C6 H11 Cl O5 | 198.602 | | 54347843 | 0 | 23 | 5 | 23 | 0 | 1 |
| 7OS | (2S,3R)-3-cyclopropyl-3-[(2R)-2-(1-{(1S)-1-[5-fluoro-2-(trifluoromethoxy)phenyl]ethyl}piperidin-4-yl)-3,4-dihydro-2H-1-benzopyran-7-yl]-2-methylpropanoic acid | | | C30 H35 F4 N O4 | 549.597 | | 127053597 | 0 | 74 | 4 | 78 | 12 | 1 |